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A technology-based system incorporating a physical activity monitor and a web interface to 
monitor dietary intake and body weight combined with monthly telephone contact has been 
shown to be an effective intervention for weight loss.  Whether this type of intervention is 
effective for individuals with Class II (BMI = 35.0 to <40.0 kg/m2) or III (BMI >40 kg/m2) 
obesity has not been examined.  Continuous enhancements in technology require ongoing 
evaluation of the effectiveness of these interventions. PURPOSE: To examine weight loss in 
response to standard behavioral weight loss (SBWL), technology (TECH), and an enhanced 
technology (TECH-BT) interventions in adults with Class II or III obesity. METHODS: 
Subjects were 39 adults (age: 39.0±9.7, BMI: 39.5±2.8kg/m2) randomized to SBWL (n=14), 
TECH (n=12), or TECH-BT (n=13).  The prescription for all subjects included decreases in 
energy intake (1500-2100kcal/d), and increases in physical activity (200min/wk). SBWL 
attended weekly in-person group intervention sessions.  TECH was provided with a wearable 
activity monitor that interfaced with a web-based program to monitor dietary intake and body 
weight (BodyMedia FIT®), also with one 10-minute intervention telephone call per month.  
TECH-BT received the same component as TECH, with the technology enhanced with 
Bluetooth® capability to allow for real-time monitoring of energy balance (intake and 
expenditure)(BodyMedia LINK®).  RESULTS: Body weight was significantly reduced 
(p<.001) from 110.9±9.1 to 107.7±8.8kg in SBWL (-3.2±3.1kg; -2.9±2.9%), 112.2±10.5 to 
107.2±10.5kg in TECH (-5.0±3.7kg; 4.9±3.8%), and 108.8±15.0 to 104.0±16.2kg in TECH-BT 
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 v 
(-3.3±4.2kg; 3.5±4.8%) from 0 to 3 months.  However, weight loss was not significantly 
different between the intervention groups. While significant improvements (p<.05) were found in 
waist and hip circumferences, percent body fat, physical activity, and dietary intake, there were 
no group significant group differences. CONCLUSIONS:  These findings suggest that 
significant short-term weight loss can be achieved in individuals with Class II or III obesity with 
less in-person contact using a technology-based system combined with monthly telephone 
contact.  These findings may have significant clinical implications for effective delivery of 
weight loss interventions for severely obese adults.  Whether these findings extend beyond the 
initial 3 months of intervention and the long-term acceptability of a technology-based 
intervention warrants further investigation.  
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PREFACE 
To my Mother and Father, who always believed that I could do anything.  
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1.0  INTRODUCTION 
Age-adjusted estimates from the National Health and Nutritional Examination Survey 
(NHANES) in 2007-2008 indicate that 68% of the United States population is overweight or 
obese as defined by a Body Mass Index (BMI) of ≥ 25 kg/m2, with 33% of that representing the 
obesity prevalence at a BMI of ≥ 30 kg/m2 1. The health-related consequences of increased BMI 
are of public concern as excess body weight has been shown to be associated with higher rates of 
mortality2-5, along with chronic diseases including cardiovascular disease6-9, diabetes9-11, and 
certain cancers12-14.  In addition, overweight and obesity are related to increased risk of 
developing other health consequences such as osteoarthritis15-17, gall stones10, 18 and sleep 
apnea19-21.  In 2010, it was estimated that $117 billion was spent on the treatment of obesity and 
obesity-related comorbidities. Projections based on the rate of increase estimate that the cost of 
treating these conditions will be approximately $221 billion by 202022. Given the high 
prevalence of overweight and obesity in the United States, along with the strong body of 
evidence linking excess body weight to health consequences and chronic diseases, it is evident 
there is a need to develop novel approaches to reducing overweight and obesity.  
 
 
. 
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1.1 BACKGROUND 
Improvements in health consequences related to overweight and obesity have been demonstrated 
with modest reductions in body weight23-24. In overweight and obese individuals, weight loss has 
produced reductions in hypertension25-26 and blood lipids27. In addition, blood glucose has been 
shown to decrease, and insulin sensitivity has been shown to increase28. The Diabetes Prevention 
Program demonstrated a 58% reduction in risk of developing diabetes in individuals with 
impaired glucose tolerance that had an initial weight loss after one year of 7.2%, with 4.5% loss 
maintained after 3 years28.  More recently the multi-center Look AHEAD Study has shown that 
similar magnitudes of weight loss at one and four years in adults with type 2 diabetes can result 
in improvements in numerous traditional cardiovascular disease risk factors29-30.  Thus, lifestyle 
interventions are recommended to reduce body weight that can result in improvements in health 
risk. 
Interventions that focus on reducing energy intake (diet) and increasing energy 
expenditure (exercise or physical activity) are typically most effective if combined with 
behavioral strategies to facilitate engagement in and maintenance of these behaviors.  This 
approach is consistent with the clinical guidelines for obesity treatment issued by the National 
Institutes of Health (NIH)24 and other leading professional organizations including the American 
College of Sports Medicine23, the American Dietetic Association31 , and the American Heart 
Association32--33.  These types of interventions have demonstrated a reduction of initial body 
weight of approximately 8-10% across a period of 21-24 weeks34.   Traditionally, these 
interventions have required onsite face-to-face contact between patients and weight loss 
counselors, which can result in patient burden and make these approaches less appealing to some 
patients.   
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There has been an increase in the use of technology and alternative delivery channels 
(mail, web-based, telephone), and these interventions have resulted in significant weight loss 
without requiring in-person contact between the patient and counselor.  Recently, Pellegrini et 
al.35 reported that the use of a technology-based system that included a wearable device to 
monitor energy expenditure and a web-based interface to report dietary intake, combined with 
one brief monthly telephone call from a weight loss counselor resulted in similar changes in 
body weight (-5.8 ± 6.6 kg, 6.3 ± 7.1%) when compared to an in-person intervention that did not 
include this technology (-3.7 ± 5.7 kg, -4.1 ± 6.3%). However, these findings warrant replication, 
which was one of the specific aims of this proposed study.  Moreover, examining whether 
additional enhancements to this technology-based intervention would result in even greater 
weight loss would be of clinical significance thus was an additional aim of this study.  
1.2 THEORETICAL RATIONALE SUPPORTING THE EFFECTIVENESS OF 
TECHNOLOGY FOR WEIGHT LOSS 
Behavioral weight loss programs typically integrate the concept of self-regulation as a crucial 
strategy for changing dietary intake and physical activity behaviors34. Based on the Social 
Cognitive Theory of Self-regulation developed by Bandura, two key components to self-
regulation include self-monitoring and feedback on the progress of behaviors36.  Thus, part of the 
effectiveness of the technology-based intervention (BodyMedia® FIT System, Pittsburgh, PA) 
implemented by Pellegrini et al.35 may be explained by the technology facilitating self-
monitoring and feedback of key weight loss behaviors, namely physical activity and dietary 
intake.  The BodyMedia® FIT System includes a wearable device to monitor physical activity 
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and energy expenditure in real-time, a display device to provide feedback on achievement of 
energy expenditure and physical activity goals, and a web-based software program to provide 
self-monitoring of dietary intake and to provide feedback on goal achievement.  Moreover, the 
intervention staff was able to access this information via a web-interface and provide further 
feedback on goal achievement of these key behaviors during monthly telephone counseling 
contact.   
Self-monitoring of dietary behaviors has consistently been shown in the literature to be 
associated with greater reductions in weight compared to not self-monitoring33-34, or self-
monitoring less frequently37-41. Noland et al. reported that individuals who self-monitored 
physical activity reported a significantly greater number of exercise sessions compared to those 
that did not42.  Regular self-weighing of body weight has also been shown to be associated with 
improved weight loss outcomes39.  Feedback in reference to self-monitoring of dietary and 
physical activity behaviors may be an effective strategy to promote weight loss43.  Within Social 
Cognitive Theory36, Bandura states that knowledge of how one is doing, in the form of feedback, 
may alter subsequent behaviors potentially triggering self-reactive influences towards achieving 
goals. Feedback offers important information specifically related to reaching more direct 
decisional considerations, increasing engagement, increasing motivation, and providing 
comparison and norms to base future goals upon44. The success of self-regulation relies partly on 
the temporal proximity of feedback related to self-monitoring36. 
Figure 1 represents a theoretical model depicting the pathway by which both self-
monitoring and feedback may contribute to behavior change resulting in weight loss.  Within the 
model, goals for both dietary modification and physical activity are established that should result 
in weight loss.  Key in this concept is the need to self-monitor each of these behaviors.  Self-
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monitoring results in feedback on achievement of behavioral goals, and depending on goal 
achievement, additional changes to these key behaviors are undertaken by the individual. 
Behaviors     
• Dietary Modification    Feedback 
• Physical Activity     
     
 Self-Monitoring   
    
Body Weight Change     
 
Figure 1. Self-regulation within behavioral weight loss interventions 
The findings of Pellegrini et al. 35 show that use of the BodyMedia® FIT System in 
combination with monthly intervention contact via telephone was as effective as a more 
intensive in-person weight loss intervention, and this may be a result of the technology 
enhancing the components of self-regulation, specifically self-monitoring and feedback.  These 
findings needed replication, which was a focus of this proposed study.  In addition, the 
technology used by Pellegrini et al. 35 required individuals to use a computer to self-monitor 
eating behavior, which prohibited this from occurring in real-time and may have reduced 
effectiveness.  Moreover making the physical activity data available to the counselor also 
required the participant to upload the data from the armband to the website using a computer, 
which again may have reduced effectiveness.  More recent developments allow the participant to 
use smart phones to self-monitor eating behavior in real-time and to have the physical activity 
visible without connecting to a computer, which may improve the effectiveness of this 
technology.  However, these enhancements in the technology had not been evaluated within the 
context of an intervention for weight loss, which was the second focus of this proposed study.  
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1.3 SPECIFIC AIMS 
1. To examine the effect of standard behavioral weight loss (SBWL), BodyMedia® FIT 
System combined with a monthly intervention telephone call (TECH), and an Enhanced 
BodyMedia® FIT System combined with a monthly intervention telephone call (TECH-
BT) on weight loss across 3 months in overweight and obese adults.  
2. To examine the effect of SBWL, TECH, and TECH-BT on change in body composition 
as measured with percent body fat, waist circumference, and hip circumference across 3 
months in overweight and obese adults.  
3. To examine the effect of SBWL, TECH, and TECH-BT on changes in moderate-to-
vigorous intensity physical activity across 3 months in overweight and obese adults.  
4. To examine the effect of SBWL, TECH, and TECH-BT on changes in dietary intake 
across 3 months in overweight and obese adults.  
5. To examine the effect of SBWL, TECH, and TECH-BT on self-monitoring of diet, 
physical activity, and body weight across 3 months in overweight and obese adults.  
1.4 HYPOTHESES 
1. It was hypothesized that TECH-BT would result in a significantly greater weight loss 
compared to SBWL and TECH across a 3-month intervention.  
a. An exploratory hypothesis was that there was no significant difference for weight 
loss between SBWL and TECH.  
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2. It was hypothesized that TECH-BT would result in a significantly greater reduction in 
percent body fat, waist circumference, and hip circumference compared to SBWL and 
TECH across a 3-month intervention.  
a. An exploratory hypothesis was that there would be no significant difference in 
these measures between SBWL and TECH.  
3. It was hypothesized that TECH-BT would result in a significantly greater amount of 
moderate-to-vigorous physical activity compared to SBWL and TECH across a 3-month 
intervention.  
a. An exploratory hypothesis was that there would be no significant difference in 
moderate-to-vigorous physical activity between SBWL and TECH.  
4. It was hypothesized that TECH-BT would result in significantly greater improvement in 
dietary intake and eating behavior compared to SBWL and TECH across a 3-month 
intervention. 
a. An exploratory hypothesis was that there would be no significant difference in 
these measures between SBWL and TECH.  
5. It was hypothesized that TECH-BT would self-monitor (dietary intake, physical activity, 
and body weight) at a greater frequency compared to SBWL and TECH across a 3-month 
intervention.  
a. An exploratory hypothesis was that there would be no significant difference in 
these measures between SBWL and TECH.  
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2.0  REVIEW OF THE LITERATURE 
2.1 OBESITY: DEFINITION AND PREVALENCE 
Overweight and obesity is defined as having excess body weight or body fat. Body mass index 
(BMI) is calculated by weight in kilograms divided by height in meters squared24. Overweight is 
defined as a BMI of 25.0 to < 30.0 kg/m2 with obesity defined as a BMI of ≥ 30.0 kg/m2. Obesity 
can be divided into classes based on severity: Class I, BMI of 30.0 to < 35.0 kg/m2; Class II, 
BMI of 35.0 to < 40.0 kg/m2; and Class III, BMI of ≥ 40.0 kg/m2 24, 44. Age-adjusted estimates 
from the National Health and Nutritional Examination Survey (NHANES) in 2007-2008 indicate 
that 68% of the United States population is overweight or obese, and 33% of that represents the 
obesity prevalence.1 The epidemic of overweight and obesity is demonstrated with high 
prevalence rates found across the United States impacting both genders, the majority of racial 
and ethnic groups, and all socioeconomic tiers44-46. 
2.2 CONSEQUENCES OF OBESITY 
The consequences of obesity have influenced health and quality of life in addition to having a 
large economic impact on society. Consistently, the literature has established that a higher BMI 
is related to increased risk of mortality 2-5. Age-adjusted analyses in the Nurses’ Health Study2 
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demonstrate a J-shaped association between increasing BMI and mortality, with women having a 
BMI of 19.0 to 26.9 kg/m2 at the lowest risk. Results indicate a positive association with 
increasing BMI and relative risk of mortality from all causes3-5. The American Cancer Society’s 
Cancer Prevention Studies I and II3, 4 demonstrated similar trends in the relationship between 
increasing BMI and risk of mortality with highest rates associated with a BMI of ≥ 32.0 kg/m2 in 
men and women (2.68, 95% CI: 1.76-4.08; and 1.89, 95% CI: 1.62-2.21). The risk of death 
increased with higher BMI in all age groups and for all cause of death categories. Flegal et al.5 
examined cause-specific relative risks of mortality in relation to BMI using NHANES data 
combined with cause of death data from the 2004 United States vital statistics. Results from this 
study demonstrated a significant and positive association between excess mortality and 
cardiovascular disease (CVD) mortality in obese, but not overweight BMI categories.   
The development of chronic health conditions related to overweight and obesity has a 
similar pattern of associated risk. High levels of body fat have been shown to be involved in the 
pathogenesis of hypertension, insulin resistance, hyperlipidemia, and certain cancers 6-14, 48. 
Excess body fat is also considered a risk factor for cardiovascular disease 49. After 26 years of 
follow-up in the Framingham Heart Study, the risk of cardiovascular death increased by 1% for 
every pound increase in body weight for subjects 30-42 years of age, and by 2% for subjects 
between the ages of 50 and 6250. Overweight and obesity have also been related to increased risk 
of developing other health consequences such as osteoarthritis 15-17, gallstones 10,18, and sleep 
apnea 19-21. Central adiposity has been shown to be an independent risk factor for co-morbidities 
related to overweight and obesity24. Evidence from the Nurses’ Health Study shows that after 
adjusting for BMI and other cardiac risk factors, a waist circumference of ≥ 96.5 cm (38 in) in 
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women was associated with a greater relative risk of developing coronary heart disease (3.06, 
95% CI: 1.54-6.10) 51. 
Overweight and obesity have also been linked with lower health-related quality of life 
(HRQL) and physical limitations. Studies have demonstrated significant decreases in quality of 
life as a result of obesity. The Behavioral Risk Factor Surveillance System (BRFSS) shows that 
the severely obese (BMI ≥ 35 kg/m2) and obese (BMI 30.0 kg/m2) were more likely to 
experience unhealthy days affecting physical health (OR=1.87 and 1.11), mental health 
(OR=1.41 and 1.17), and activity limitations (OR=1.73 and 1.22) compared to a normal weight 
reference (BMI < 25.0 kg/m2)52. Compared to age-matched men of normal weight (BMI < 25.0 
kg/m2), Larsson et al. found that men in the highest category of BMI (30.0 to <40.0 kg/m2) had 
significantly lower HRQL scores for physical functioning (94.4, SE=1.5, p ≤ .05), general health 
(73.5, SE=2.5, p ≤ .01) , vitality (61.0, SE=2.9, p ≤ .01), and social functioning (84.4, SE=2.9, p 
≤ .05). Compared to age-matched women of normal weight (BMI < 25.0 kg/m2), women in the 
highest category of BMI (30.0 to < 40.0 kg/m2) had significantly lower HRQL scores for 
physical functioning (90.8, SE=21.9, p ≤ .01), bodily pain (72.5, SE=3.2, p ≤ .05), and general 
health (50.0, SE=1.0, p ≤ .01)53. Compared to normal weight subjects, obese subjects (BMI 
>30.0 kg/m2) have also reported a higher prevalence of falls (27% vs. 15%) and ambulatory 
stumbling (32% vs. 14%), with HRQL scores significantly lower in terms of physical 
functioning, vitality, bodily pain, and general health 54.  
It is suggested that obesity is related to depressive disorders along with other mental 
illnesses 44, 55. Overweight subjects (BMI ≥ 25.0 kg/m2) demonstrate a higher prevalence of 
depression compared to those with a BMI of < 25.0 kg/m2. Compared to non-overweight 
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controls, the odds ratio for overweight individuals to have depression and bodily dissatisfaction 
is 4.63 and 2.25, respectively55.  
In addition to the adverse effects on health, the high prevalence of overweight and 
obesity has adverse effects on the economy. Obesity-related conditions are among the most 
expensive health care problems as treatment of these comorbidities is associated with greater 
cost and use of health care services56. A reported 36% increase in medical expenditures is related 
to the treatment of obesity-related conditions when compared to medical expenses from normal-
weight patients57. In 2010, it was estimated that $117 billion was spent on the treatment of 
obesity and obesity-related comorbidities. Projections based on the rate of increase estimate that 
the cost of treating these conditions to be approximately $221 billion by 202022. A large portion 
of this cost is covered through government supported medical providers such as Medicare and 
Medicaid costing taxpayers approximately $175.00 to a projected $200.00 or greater per person 
per year22,58. 
2.3 WEIGHT LOSS AND IMPROVED HEALTH CONSEQUENCES 
Improvements in health consequences related to overweight and obesity have been demonstrated 
with modest reductions in body weight23-24. In overweight and obese individuals, weight loss has 
produced reductions in hypertension25-26, blood lipids27, and blood glucose has been shown to 
decrease, and insulin sensitivity has been shown to increase26. The Diabetes Prevention Program 
demonstrated a 58% reduction in risk of developing diabetes in individuals with impaired 
glucose tolerance that had an initial weight loss after one year of intervention of 7.2%, with 4.5% 
loss maintained after 3 years28.  More recently the multi-center Look AHEAD Study has shown 
  12 
that similar magnitudes of weight loss at one and four years in adults with type 2 diabetes can 
result in improvements in numerous traditional cardiovascular disease risk factors29-30.   
An early review of the medical benefits of weight loss suggests that improvements in 
insulin resistance, serum glucose levels, and systolic and diastolic blood pressures can be 
achieved in the short-term25. MacMahon et al. reported that a significant decrease in systolic and 
diastolic blood pressure (13 and 10 mmHg) was associated with a mean group weight loss of 7.4 
kg after 21 weeks59. Ross et al. have demonstrated improvements in glucose disposal following 
diet- (5.6mg/kg skeletal muscle/min) and exercise-induced (7.2mg/kg skeletal muscle/min) 
weight loss across 12 weeks60.  Four-month improvements in insulin sensitivity (5.9 ± 0.4 to 7.3 
± 0.5 mg/fat-free mass/min) have been demonstrated by Goodpaster et al. following significant 
weight losses (baseline 100.2 ± 2.6 to 4-month 85.5 ±2.1 kg)61. Goodpaster et al. have also 
demonstrated significant improvements in fasting insulin levels following diet (baseline 15.83 to 
6-month 11.61 uU/mL, p < 0.001) and diet plus exercise (baseline 17.07 to 6-month 12.06 
uU/mL, p < 0.001) weight loss interventions62.  
2.4 INTERVENTIONS FOR WEIGHT LOSS 
2.4.1 Standard Behavioral Weight Loss Interventions 
Lifestyle interventions that focus on reducing energy intake (diet) and increasing energy 
expenditure (exercise or physical activity) are typically most effective if combined with 
behavioral strategies to facilitate engagement in and maintenance of these behaviors. This 
approach is consistent with the clinical guidelines for obesity treatment issued by the National 
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Institutes of Health (NIH)24 and other leading professional organizations including the American 
College of Sports Medicine23, the American Dietetic Association31 , and the American Heart 
Association32-33.  These types of interventions have demonstrated a reduction of initial body 
weight of approximately 8-10% across a period of 21-24 weeks34. Early work by Wing et al. 
demonstrated that after 10 weeks of basic dietary intervention without specific caloric 
prescription, weight loss programs produced a 4.5 kg weight loss63.  
Changes to behavioral weight loss intervention in the last 20 years have included dietary 
prescriptions reducing daily calories by approximately 500-1,000 kcal/day23, and gradually 
increasing physical activity energy expenditure to 1,00034 to 1,500 kcals63 per week. This 
combination produces a negative energy balance creating a 1-2 pound weight loss per week 23. 
According to Wing et al. participants in behavioral weight loss programs in the 1990’s lost 9.0 
kg, or approximately 10% of initial body weight34.   
A more recent trial demonstrated similar changes in body weight when examining 
differences in intermittent (-9.3 ± 4.5 kg) versus continuous (-10.2 ± 4.2 kg) exercise within a 
behavioral weight loss intervention64. Jakicic et al. have shown similar results in a later trial with 
participants losing 8.1 ± 5.0 kg (-9.3 ± 5.6%) of initial body weight across 6 months65. In a 
population of severely obese adults (BMI: 43.5 ÷ 4.8, 43.7 ± 5.9 kg/m2) across 6 months, 
Goodpaster et al. demonstrated significant changes in body weight in diet only (-8.2 kg) versus 
to diet plus exercise (-10.9 kg) interventions, with approximately a 2 kg additional change in 
body weight found in the diet plus exercise condition62. The addition of exercise to dietary 
weight loss interventions has been shown to produce an additive 2-3 kg change in body weight as 
compared to diet interventions alone67. 
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2.4.2 Technology-based Weight Loss Interventions 
In the past 10 years, there has been an increase in the use of technology to deliver weight loss 
interventions. The availability of the Internet, with 73% of adults having access in 2011, has led 
to its incorporation in the delivery of weight loss interventions 68. Web-based interventions have 
resulted in significant weight losses while reducing in-person contact.  
Tate et al. examined the use of the Internet to deliver education on weight loss compared 
to a behavioral weight loss intervention69. Participants in the Internet behavior group lost 
significantly more weight than those in the education group from baseline to 3 months (p = 
.001), with 45% of the participants in the Internet behavior group losing ≥ 5% of initial body 
weight. In the Internet behavior group, the total number of self-monitoring diaries submitted 
online was correlated with weight loss (r =-.05, p =.001).69  
A pilot study by Gold et al. compared changes in body weight from an interactive 
behavioral weight loss website and a commercial website70. Repeated measures analysis showed 
that the behavioral weight loss website group (-8.3 ±7.9 kg) lost significantly more weight than 
the commercial website group (-4.1 ± 6.2 kg) (p = .004) after 6 months.  
Tate et al. also examined the role of counseling using the Internet within a weight loss 
intervention71.  In addition to having access to an interactive website, participants in this design 
were randomized to receive no counseling, automated email counseling generated by a computer, 
or personalized email counseling from a human counselor. At 3-months, the two groups 
receiving email feedback had similar magnitudes of weight loss whether by computer (-5.3 ± 4.2 
kg) or counselor (-6.1 ±3.9 kg), and a greater loss compared to no counseling controls across 3 
months. However, at 6 months, the group receiving human email counseling had a significantly 
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greater weight loss (-7.3 ± 6.2 kg) compared both the computer email group (-4.9 ± 5.9 kg) and 
no counseling controls (-2.6 ± 5.7 kg).  In both computer and counselor feedback groups, the 
total number of self-monitoring diaries submitted online was associated with weight loss (r = -
.69 and -.56, p<.001).  
To understand the level of in-person contact needed to support technology-based 
interventions, Micco et al72 randomized 183 participants into two groups, Internet only or 
Internet plus in-person treatment. Results showed no significant difference in weight loss 
between the groups at 6 months (-6.8 ± 7.8 kg vs -5.1 ± 4.8 kg, p=.15). More recently, Harvey-
Berino et al.73 conducted a study to compare traditional in-person, interactive Internet, and a 
hybrid intervention incorporating both in-person contact and interactive Internet interventions. 
Conditions differed significantly in mean weight loss (-8.0 ± 6.1 kg, -5.5 ± 5.6 kg, -6.0 ± 5.5 kg; 
p<.01) for in-person, Internet, and hybrid, respectively. The in-person group had a significantly 
higher proportion of participants achieving a 7% weight loss (56.3%) as compared to hybrid 
(44.4%) and Internet (37.3%) conditions. These results suggest that in-person contact had a 
greater impact on weight loss; however, it should be noted that even though not significantly 
different from the other group, the hybrid intervention provided a trend towards an increase in 
weight loss as compared to Internet alone.  
The magnitude of weight loss in the Internet-based studies appears to be less than that 
observed in SBWL interventions; however, recent technology enhancements integrating a 
wearable physical activity monitor have shown promising results. The BodyMedia® FIT System 
incorporates a physical activity monitor worn on the upper arm that works in conjunction with a 
web-interface for self-monitoring of daily energy expenditure and energy intake. In a 12-week 
study examining the efficacy of this system, Polzien et al., compared a standard in-person 
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intervention to a standard in-person plus the technology-based system used both intermittently 
and continuously74. Results from this study demonstrated that greater weight losses were 
reported when the technology was used continuously, (-6.2 ± 4.0 kg) compared to intermittent 
usage (-3.4 ± 3.4 kg); however, the addition of the technology-based system produced a non-
significant (p = 0.08) 2 kg decrease in body weight compared to in-person intervention alone. A 
significant correlation was observed between change in body weight from self-monitoring of 
physical activity (armband time on body) in both intermittent technology (r = -.68, p < .01) and 
continuous technology (r = -.71, p < .01) groups, and change in body weight from self-
monitoring of meals on the web-interface in the continuous technology group (r = -.50, p < .05).   
Pellegrini et al. examined the use of a similar technology-system with a once per month 
telephone intervention35. This study reported greater weight losses in the standard in-person plus 
technology group (-8.8  ± 5.0 kg) compared to standard in-person intervention (-7.1 ± 6.2  kg), 
and consistent with Polzien et al.74, the use of the technology system assisted with an additional 2 
kg decrease in body weight. Subjects in the standard plus technology group self-monitored eating 
behaviors significantly more (5.9 ± 2.2 days/week) than those in the standard alone group (5.3 ± 
2.8 days/week) with dietary intake significantly related to weight loss at 6 months (r = -.57, 
p<.01). The technology plus telephone intervention group had similar changes in body weight 
(completers: -5.8 ± 6.6 kg, intent-to-treat: -6.3 ± 7.1%) when compared with in-person 
intervention that did not include the technology (completers: -3.7 ± 5.7 kg, intent-to-treat: -4.1 ± 
6.3%).  
Using the same technology system in a weight loss intervention, Shuger et al.75 
randomized subjects into 4 groups: self-directed standard care (SC), group-based weight loss 
(GWL), GWL plus armband technology (GWL+SWA), and armband technology used alone 
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(SWA-alone). There was a significant reduction in body weight in SWA-alone from baseline 
(101.15 ± 2.95 kg) to 4 months (98.48 ± 2.97 kg) and in GWL+SWA (baseline 100.32, ± 2.97 kg 
to 4 months 96.83 ± 2.99 kg). Significant reductions in waist circumference were also seen after 
4 months in SWA-alone (baseline 105.91 ± 2.18 cm to 4 months 102.99 ± 2.21 cm) and 
GWL+SWA (baseline 106.04 ± 2.19 to 4 months 102.12 ± 2.21 cm). No differences in body 
weight were found between the intervention groups, however results after 9 months showed a 
significant body weight reduction in GWL+SWA compared to SC (p = .0004). The lower 
magnitude of weight loss in the SWA-alone group may be explained by the complete removal of 
contact as compared to the Pellegrini study35 in which a once-monthly telephone contact was 
made with participants.  Conflicting results from Shuger et al.75 and Pellegrini et al.35 suggest 
that the efficacy of this type of technology-based system used with minimal in-person contact 
should be further investigated.   
2.5 SELF-MONITORING AND FEEDBACK 
Based on the Social Cognitive Theory of Self-regulation developed by Bandura, two key 
components to self-regulation include self-monitoring and feedback on the progress of 
behaviors36.   Self-monitoring is defined as the systematic observation and recording of target 
behaviors76 that promotes self-awareness77-79. Within the Social Cognitive Theory of Self-
Regulation, Bandura states that it is difficult for people to influence their own motivation and 
actions if they do not pay adequate attention to their behavior performance36. Thus self-
monitoring provides information needed for realistic and progressive goal setting, while assisting 
with the evaluation of goal achievement to better influence behavior change36,77-79. It has been 
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suggested that self-monitoring is one of the most critical components of behavior change78,80, and 
it is frequently used as a strategy when modifying behaviors associated with weight loss. Early 
research by Fisher et al. emphasized self-monitoring in weight management. Findings from this 
study show that those who did not self-monitor over a 3-week holiday gained approximately 5.7 
times as much weight as those that sustained self-monitoring behaviors81. Work by 
Kirschenbaum et al. 78,82-83 supports these findings suggesting that the discontinuation of self-
monitoring results in discontinuation or failure of self-regulation.  
Baker et al.84 examined the relationship between self-monitoring and weight change. 
Results after 12-weeks demonstrate that six variables: monitoring of any food consumed (r=.42, 
p<0.001) monitoring of all foods eaten in a day (r=.44, p<0.001), monitoring of time food was 
eaten (r=.44, p<0.001), monitoring of the quantity of food (r=.41, p<0.001), monitoring grams of 
fat consumed (r=.35, p<0.01) and not self-monitoring (r= -.41, p<0.01) were significantly 
correlated with weight change. Additional analysis divided subjects into high and low categories 
based on overall consistency and completeness of self-monitoring, with the highest category 
losing significantly more weight than the category with the lowest level of monitoring (p < .01). 
When divided into self-monitoring quartiles after 12 weeks, greater percentages of subjects lost 
weight in the quartiles that reflected greater levels of consistency and completeness. Boutelle et 
al. replicated these findings over an 8-week period demonstrating that the most consistent self-
monitors lost more weight than the least consistent self-monitors85.   
Carels et al.86 examined the relationship between exercise self-monitoring and weight 
loss. After 15.8 ± 6.2 weeks of exercise monitoring, a significant and positive relationship was 
shown between higher levels of self-monitoring and greater weight losses (r = .44, p < .05), and 
greater cumulative exercise minutes (r = .52, p <. 01). Secondary analyses examining consistent 
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versus inconsistent exercise self-monitoring revealed that consistent self-monitors lost 
significantly more weight (p < .05); participated in greater cumulative exercise minutes (p < .01); 
and reported fewer difficulties with exercise (p < .01).  
Burke et al. in a qualitative analysis of participants within a weight reduction program 
concluded that individualizing self-monitoring strategies may improve adherence to the behavior 
87. Among the current self-monitoring strategies utilized, paper diaries have classically been used 
within weight loss interventions88-93, however reports use of electronic diaries69,71,92-93 and 
personal digital assistant (PDAs)94-97 have recently emerged. These technological enhancements 
in self-monitoring may simplify the process and allow for temporal and meaningful feedback 
consistent with constructs of the Social Cognitive Theory of Self-Regulation 36. Bandura also 
states that feedback, or knowledge of how one is doing, may alter subsequent behaviors 
potentially triggering self-reactive influences towards achieving goals. A review of the literature 
supporting the role of feedback in behavior change concludes that feedback offers important 
information specifically on reaching more direct decisional considerations, increasing 
engagement, increasing motivation, and providing comparison and norms upon which to base 
future goals44.  
2.6 SUMMARY 
Overweight and obesity is of major concern due to the high prevalence1 and 
consequences affecting physical6-21,48-50 and mental health45,.54, along with quality of life and 
physical and mental function52-55.  Improvements in health outcomes related to overweight and 
obesity have been demonstrated with modest reductions in body weight23-24, and behavioral 
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weight loss interventions have been successful at producing the magnitude of weight loss 
necessary to see these changes28-30,35,62,65,67. Recent technology advances have demonstrated that 
significant weight loss can potentially be achieved with less in-person contact35. The benefit of 
this technology is the potential to improve the temporal proximity of self-monitoring which is 
consistent with Bandura’s Social Cognitive Theory of Self-Regulation36.  When applying this 
model to a weight loss intervention, goals for both dietary modification and physical activity are 
established that should result in weight loss.  Key in this concept is the need to self-monitor each 
of these behaviors.  Self-monitoring results in feedback on achievement of behavioral goals, and 
depending on goal achievement, additional changes to these key behaviors are undertaken by the 
individual. This study is designed to examine whether recent enhancements to the existing 
technology may facilitate self-monitoring and feedback on goal achievement, ultimately 
resulting in improved weight loss compared to alternative weight loss interventions. The 
theoretical pathway to be examined in this study is shown in Figure 2. 
 
Behaviors     
• Dietary Modification    Feedback 
• Physical Activity     
     
 Self-Monitoring   
    
Body Weight Change     
 
Figure 2. Self-regulation within behavioral weight loss interventions 
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3.0  METHODOLOGY 
3.1 SUBJECTS 
Eighty four (N=84) men and women between the ages of 21-55 years were recruited to 
participate in this study. Subjects were sedentary and classified as Class II and Class III obese 
adults based on Body Mass Index (BMI) (35.0 – 45.0 kg/m2). While severe obesity has been 
shown to be associated with a greater number of comorbidities24, only one study included adults 
with Class III obesity when examining the effectiveness of the BodyMedia® FIT system for 
weight loss75.  Subjects meeting the American College of Sports Medicine (ACSM) criteria for 
classification of low to moderate risk were eligible for participation in this study, with those 
classified as high risk excluded from the study49. Additionally, individuals meeting the following 
conditions were excluded: 
1. Reported not having access to a computer, access to the Internet, or the availability to 
download software onto a computer.  
a. Rationale:  The BodyMedia® FIT System required the usage of a computer with the 
above capabilities. Not having this access would result in the reduced ability to utilize 
the technology as a tool to assist with monitoring of weight loss behaviors.  Funds 
were not available to provide a compatible computer to participants in this study.  
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2. Reported not having a smart phone that is compatible with the BodyMedia® FIT Bluetooth® 
System that was examined in this study.  
a. Rationale:  Not having access to this technology prohibited use of the technology 
system that is being examined in one of the intervention conditions for this study.  
Funds were not available to provide the necessary smart phone device to participants 
in this study.  
3. Had a physical limitation that prevented engaging in physical activity.  
a. Rationale:  The ability to perform physical activity was a necessary component in all 
three intervention groups. This type of limitation reduced the capability of assessing 
changes to physical activity behaviors as a part of the weight loss study.  
4. Participated in structured aerobic exercise for ≥ 60 minutes per week over the prior ≥ 3 
months.  
a. Rationale:  The inclusion of only sedentary individuals allowed for the examination 
of changes in physical activity behaviors over the course of the study.  Recruiting 
individuals who were already physically activity would limit the influence of the 
proposed interventions on improvements in this behavior.  
5. Reported being treated for a current medical condition that could affect body weight. These 
may have included the following: cancer; diabetes mellitus; hyperthyroidism; inadequately 
controlled hypothyroidism; chronic renal insufficiency; chronic liver disease; gastrointestinal 
disorders including ulcerative colitis, Crohn’s disease, or malabsorption syndromes, etc. 
a. Rationale:    The presence of these medical conditions would confound the results of 
this study. 
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6. Reported current congestive heart failure, angina, uncontrolled arrhythmia, symptoms 
indicative of increase risk of an acute cardiovascular event, coronary artery bypass grafting 
or angioplasty, prior myocardial infarction, and conditions requiring anticoagulation therapy 
(i.e. deep vein thrombosis).  
a. Rationale:  Individuals with these types of medical conditions require additional 
clearance, supervision, and changes in the prescription of dietary and physical activity 
goals, which was outside of the projected scope of this study.  These types of 
alterations would be different from the standard procedures used within the 
intervention groups being proposed.  
7. Had a resting systolic blood pressure ≥ 150 mmHg or resting diastolic blood pressure of ≥ 
100 mmHg or taking medications to control blood pressure.  
a. Rationale:  Hypertension at these levels may have contraindicated participation in the 
prescribed physical activity as a part of the weight loss study or may require 
additional screening or medical management. 
8. Treatment for any psychological issues (i.e., depression, bipolar disorder, etc) or taking 
psychotropic medications within the previous 12 months.  
a. Rationale:  Interventions for psychological issues may have affected compliance, 
potentially confound the effect of the proposed intervention, or may require additional 
medical monitoring throughout the study period. Psychotropic medications are 
exclusionary, as certain types have been shown to affect body weight.  
9. Had taken prescription or over-the-counter medications that affect body weight and 
metabolism.  
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a. Rationale:  Medications that affect body weight may have confounded the results of 
this study.  
10. Had lost > 5% of current body weight in the prior 3 months and maintained that weight loss 
at the time of recruitment.  
a. Rationale:  Previous experiences with this type of intervention have shown that 
maintained weight losses > 5% in the previous 3 months tend to move the 
intervention to focus to the prevention of weight regain as opposed to weight loss, 
which was one of the primary outcomes of the proposed study.  
11. Was a participant in an exercise or weight control study, had participated in an exercise or 
weight control study within the previous 6 months, or was a current participant in a 
commercial weight reduction program.  
a. Rationale:  Concurrent involvement in these types of programs or research studies 
may have confounded the weight loss intervention proposed for this study.  
12. Had undergone bariatric surgery (e.g., gastric bypass, lap-band) for weight loss. 
a. Rationale:  Bariatric surgery may have required alterations in the proposed diet and 
physical activity intervention, and may have confounded the outcome variables for 
this study. 
13. Had been treated for an eating disorder. 
a. Rationale:  The presence of an eating disorder may have required additional medical 
monitoring and may have confounded the results of this study. 
14. Was pregnant, pregnant in the last 6 months, breast feeding in the last 3 months, lactating, or 
planning on becoming pregnant in the next 3 months.  
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a. Rationale:  Pregnancy would have required modification to the intervention and may 
have required additional medical monitoring.  Recent pregnancy or breast feeding 
may have confounded the outcomes of this study.  
15. Planned to relocate outside of the greater Pittsburgh area within 3 months. 
a. Rationale:   Individuals planning on relocating may have not completed the study, 
which would have increased attrition. 
3.2 RECRUITMENT 
Subjects were recruited through local flier mailings and television advertisements. Additionally, 
letters were mailed to individuals meeting eligibility requirements registered in the Obesity and 
Nutrition Research Center database. All recruitment materials were approved by the University 
of Pittsburgh Institutional Review Board (IRB).  
Potential participants were instructed to contact the Physical Activity and Weight 
Management Research Center by telephone where trained staff and graduate students conducted 
telephone screenings to determine eligibility. A description of the study and telephone screening 
procedures were first provided to the potential participant. Upon receiving verbal consent, the 
individual answered a series of questions to determine initial eligibility, which included 
questions regarding demographics (age, BMI, etc.), physical health, and medical history 
(Appendix A).   
Individuals that appeared eligible based on the telephone screening were invited to attend 
an orientation session in which participants learned about the details of the study from the 
Principal Investigator (PI), and had the opportunity to ask questions about any components of the 
  26 
study and to have these questions answered to their satisfaction. After attendance at an 
orientation session, those interested in participating in the study were asked to read and sign the 
informed consent document that was approved by the University of Pittsburgh IRB.  After 
providing written informed consent, participants completed a Physical Activity Readiness 
Questionnaire (PAR-Q)97 and medical history, and provided medical clearance from their 
primary care physician prior to being eligible to undergo additional baseline assessments. The 
baseline assessments included measures of height, body weight, Body Mass Index (BMI), 
regional adiposity by anthropometry, blood pressure, heart rate, bioelectrical impedance analysis 
(BIA) for percent body fat, physical activity, and dietary intake and behaviors.  
 
Figure 3. Study progression 
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3.3 EXPERIMENTAL DESIGN AND STUDY TIMELINE 
This study used a randomized pretest and post-test design.  Eligible participants were 
randomized to one of three intervention groups: Standard Behavioral Weight Loss (SBWL), 
BodyMedia® FIT System combined with a monthly intervention telephone call (TECH), or 
Enhanced BodyMedia® FIT System combined with a monthly intervention telephone call 
(TECH-BT).   Outcome assessments were performed at baseline (0 months) and following a 3-
month intervention.  Figure 3 illustrates the study progression with the timeline illustrated in 
Figure 4.  The interventions and assessments are described in detail below.  All study procedures 
were approved by the University of Pittsburgh IRB prior to implementation.  
 
Figure 4. Study timeline 
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3.4 DESCRIPTION OF INTERVENTIONS 
3.4.1 Interventions Components Common to All Randomized Groups 
3.4.1.1 Dietary Component 
Dietary recommendations were based on the subjects’ baseline body, with calorie and fat 
intake goals shown in Table 1. The calorie goals were based on intake recommendations that 
have been shown to result in successful short-term weight loss 35,62,64-65,, with fat intake goals 
consistent with the USDA Dietary Guidelines98. 
Table 1. Calorie and fat intake goals based upon body weight 
Body Weight  
(lbs) 
Caloric Intake Goal  
(kcal) 
Fat Intake Goal  
(grams) 
<175 1200 27-40 
175-219 1500 33-50 
220-249 1800 40-60 
≥250 2100 47-70 
 
To facilitate adoption and maintenance of these dietary intake goals, participants were 
provided with meal plans and sample recipes. In addition, participants were taught how to read 
food labels and were provided with The Calorie King Calorie, Fat, and Carbohydrate Counter99 
to facilitate self-monitoring of calorie and fat intake.  Participants were instructed to self-monitor 
techniques described below that were specific to each of the randomized intervention groups.  
Printed intervention lessons also included information related to behavior strategies for achieving 
the desired calorie and fat intake goals.  
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3.4.1.2 Physical Activity Component 
The physical activity component included unsupervised home-based exercise, and was 
recommended at a moderate intensity defined as 3-6 metabolic equivalents (METS), which is 
similar to brisk walking.  To facilitate adoption of this intensity of physical activity, participants 
were provided both a target heart rate (60-70% of age-predicted maximal heart rate) and rating of 
perceived exertion (11-13 on the 15-category Borg Scale)100.  Duration was initially be 
prescribed at 100 minutes per week and progressed to 200 minutes per week by 9th week of the 
intervention, which was consistent with the recommendation of the American College of Sports 
Medicine (ACSM) 23. The weekly exercise progression is shown in Table 2. Participants were 
encouraged to complete the prescribed doses of physical activity each week, with daily goals 
achieved by performing the activity in one continuous bout or accumulated across several shorts 
bouts that are each at least 10 minutes in duration64. Printed intervention lessons included 
information related to behavior strategies for achieving the desired activity goals for this study. 
Table 2. Prescribed physical activity progression 
Week Minutes/Week Minutes/Day Days/Week Intensity  (RPE) 
1-4 100 20 5 11-13 
5-8 150 30 5 11-13 
9-12 200 40 5 11-13 
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3.4.2 Intervention Components Specific to the Standard Behavioral Weight Loss Group 
(SBWL)  
The standard behavioral weight loss (SBWL) intervention took place across 3-months in which 
participants attended weekly group meetings. Group sessions ran approximately 30-45 minutes 
in length. The intervention strategies were modeled after constructs included in the Social 
Cognitive Theory33, Problem Solving Theory 101, and Relapse Prevention102. The primary focus 
of these sessions addressed barriers associated with altering physical activity participation and 
dietary intake. Intervention staff conducting the group sessions had experience in weight 
counseling with backgrounds in exercise physiology, nutrition, and/or behavioral sciences. Staff 
was trained in administering the sessions prior to the start of the intervention. Group discussions 
were facilitated by the interventionist and interactive participation was encouraged. Participants 
were provided with written materials at each meeting to supplement group discussions. 
Assessment of body weight occurred on an individual basis before or after the weekly meeting, 
and self-monitoring of body weight was emphasized during group sessions. In the event that a 
participant missed a group meeting, an interventionist engaged the participant by telephone 
initially with the goal of scheduling an in-person make-up session.  
Diaries were provided each week to assist participants with self-monitoring of calorie and 
fat consumption. The diaries also contained sections for recording daily physical activity minutes 
and intensity (RPE). On days when a participant was not physically active, space within the diary 
allowed the participant to indicate a reason (i.e., lack of time, inconvenient, lack of motivation, 
needed rest). Participants returned the diary to the intervention staff each week for review. 
Constructive feedback was provided in regards to healthier food choices, portion control, calorie 
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and fat goals, physical activity and other considerations pertinent to the content presented at the 
previous group meeting.  
3.4.3 BodyMedia® FIT System Combined with a Monthly Intervention Telephone Call 
(TECH) 
Participants in TECH did not attend the weekly group sessions.  However, the identical 
intervention materials provided to SBWL were also provided, with these materials mailed 
weekly to the participants. Participants in this group were provided with the BodyMedia® FIT 
System (BodyMedia®, Pittsburgh, PA). The BodyMedia® FIT System included a wearable 
device that monitored physical activity and energy expenditure, a display device that provided 
feedback on achievement of energy expenditure and physical activity goals, and a web-based 
software program that assisted with self-monitoring of dietary intake and to provide feedback on 
goal achievement.  This technology required that energy expenditure data from the armband 
monitor be downloaded via USB connection to a computer in order to view information 
regarding calories expended, and time and intensity of physical activities.  
Participants attended one introductory session in which a tutorial of the components of 
the FIT System that was provided. In addition, this group initially received a one-hour lesson on 
basic guidelines of the weight loss intervention. At this time, caloric goals and weekly physical 
activity recommendations were explained. To support weight loss behaviors, participants were 
encouraged to use the BodyMedia® FIT System to self-monitor dietary intake, physical activity, 
and body weight.  
Participants in the TECH group also received a scheduled intervention telephone call 
one-time per month (weeks 3, 7, 11). This telephone call took approximately 10 minutes and was 
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completed by a member of the intervention staff that was experienced using the BodyMedia® 
FIT System and trained in delivering telephone interventions. Strategies to overcome weight-loss 
barriers were primarily discussed, and a standardized script served as a guide to address technical 
difficulties using the FIT System, frequency of system usage, participant goals, barriers to diet 
and physical activity, and self-monitoring of body weight (Appendix B). Interventionists had 
access to the information uploaded to the web-interface, and this allowed the interventionist to 
review this information prior to facilitate interactions with participants during the monthly 
telephone calls. The length of each telephone intervention was recorded. 
3.4.4 Enhanced BodyMedia® FIT System Combined with a Monthly Intervention 
Telephone Call (TECH-BT) 
Participants in TECH-BT did not attend the weekly group sessions.  However, the identical 
intervention materials provided to SBWL and TECH were also provided, with these materials 
mailed weekly to the participants. Participants in this group were provided with the enhanced 
BodyMedia® FIT System (BodyMedia®, Pittsburgh, PA). In contrast to the previous version of 
the system being used by TECH, enhancements to the BodyMedia® FIT System included 
Bluetooth® technology which allowed participants to receive real-time feedback without having 
to use a personal computer or USB cable to upload physical activity data. Participants received 
the enhanced armband technology with Bluetooth® capabilities that transmitted real-time 
feedback on calories expended and physical activity time and intensity directly to a smart phone 
application (app) containing the web-interface. In addition, the smart phone app supported self-
monitoring of dietary behaviors to provide real-time feedback of goal achievement. The 
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enhancements to the FIT system allowed for self-monitoring of physical activity and dietary 
intake to occur in real-time and in one convenient location.  
The remaining procedures follow that of TECH. Participants attended one introductory 
session in which a tutorial of the components of the FIT System were provided. In addition, this 
group initially received a one-hour lesson on basic guidelines of the weight loss intervention. At 
this time, caloric goals and weekly physical activity recommendations were explained. To 
support weight loss behaviors, participants were encouraged to use the enhanced BodyMedia® 
FIT System to self-monitor dietary intake and physical activity.  
Participants in the TECH-BT group received a scheduled intervention telephone call one-
time per month (weeks 3, 7, 11). This telephone call took approximately 10 minutes and was 
completed by a member of the intervention staff that was experienced using the enhanced 
BodyMedia® FIT System and was trained in delivering telephone interventions. Strategies to 
overcome weight-loss barriers were primarily discussed, and a standardized script served as a 
guide to address technical difficulties using the FIT System, frequency of system usage, 
participant goals, barriers to diet and physical activity, and self-monitoring of body weight 
(Appendix B).  Interventionists had access to the information transmitted to the web-interface, 
and this allowed the interventionist to review this information prior to facilitate interactions with 
participants during the monthly telephone calls. The length of each telephone intervention was 
recorded. 
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3.5 ASSESSMENT PROCEDURES 
Assessment measures occurred at 0 and 3 months at the University of Pittsburgh, Physical 
Activity and Weight Management Research Center, Monday through Friday between the hours 
of 7:30am and 12:30pm. Assessments took approximately 45 minutes to complete. Assessments 
for this study included measures of height, body weight, body mass index (BMI), regional 
adiposity by anthropometry, body composition, blood pressure, heart rate, physical activity and 
dietary intake and behaviors. 
3.5.1 Height, Body Weight and BMI 
Prior to height and weight measurements, participants changed into a lightweight hospital gown 
and removed footwear. Height was measured to the nearest 0.1 cm using a wall-mounted 
stadiometer (Perspective Enterprises; Portage, MI). Body weight was measured to the nearest 0.1 
kg on a Tanita WB-110A digital scale (Tanita Corporation; Arlington Heights, IL). Duplicate 
measurements were taken and a third was completed if the initial two measurements differ by > 
0.5 cm and > 0.2 kg for height and weight respectively. BMI was calculated as the body weight 
in kilograms divided by the height squared in meters (kg/m2). At baseline, BMI was used to 
determine eligibility and baseline heights were carried forward for calculation of BMI at the 3-
month assessment point. 
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3.5.2 Regional Adiposity by Anthropometry 
Anthropometric measurements were taken in a lightweight hospital gown and measured to the 
nearest 0.1 cm using a Gulick tape measure. Duplicate measurements were taken at each site and 
a third was completed if the initial two measurements differ by > 1.0 cm. Waist circumference 
were taken at the level of the iliac crest. Measurements were taken while standing in front of the 
participant and a horizontal circumference was taken at the peak of the iliac crest as palpated 
from the mid-axillary line. Hip circumferences were taken from the side while making a 
horizontal circumference at the maximal protrusion of the gluteal muscles.  
3.5.3 Blood Pressure and Heart Rate 
Prior to assessment of resting blood pressure and heart rate, a circumference measure at the 
midpoint of the distance between the acromion and olecranon processes of the left arm was taken 
to determine the appropriate size of the blood pressure cuff. Resting blood pressure and heart rate 
measurements were obtained using the DINAMAP V100 automated blood pressure cuff (GE 
Medical System Technologies; Milwaukee, WI) following a 5-minute seated rest period. Two 
measures of blood pressure and heart rate were obtained with a one-minute rest period between 
measures. A third blood pressure was taken if the systolic blood pressure is ≥ 10 mmHg or if the 
diastolic blood pressure is ≥ 6 mmHg.  
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3.5.4 Body Composition 
Body composition was assesses using bioelectrical impedance analysis (BIA). Measurements 
were taken in a lightweight hospital gown following the removal of all jewelry from the right 
side of the body. Electrodes were placed in four locations: (1) midpoint of styloid processes at 
the right wrist; (2) joint between the knuckles of the index and middle fingers of the right hand; 
(3) midpoint of the lateral and medial malleoli of the right ankle; and (4) joint at the base of the 
great and second toes on the right foot.  The participant was asked to lay in a supine position.  
Electrical impedance of body tissues was determined by obtaining measurements of resistance 
and reactance. Lean body mass (LBM) was estimated from BIA using the equation proposed by 
Segel et al103, and this equation also incorporated measure of height, weight, age, and gender. 
Percent body fat was computed as [(weight –LBM)/weight] x 100.  
3.5.5 Physical Activity 
The Global Physical Activity Questionnaire (GPAQ)104-105 was used to assess leisure and 
recreational physical activity at all assessment time points. In addition, sedentary time was 
assessed at the all assessment periods. The questionnaire was completed in a non-interview 
format during each assessment period.  Results are reported as hours per week of total physical 
activity. 
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3.5.6 Dietary Intake and Eating Behaviors 
Dietary intake was assessed using the Block Food Frequency Questionnaire (FFQ) (Block, 
2005.1). This questionnaire has been validated106-107 in estimating daily caloric intake.  Data are 
represented as daily caloric intake and percent of calories consumed from dietary fat. 
The Eating Behavior Inventory (EBI) is a 26-point checklist that was used to measure 
eating behaviors108.This questionnaire assesses behaviors that may be related to successful 
weight loss such as self-monitoring of intake, refusing food, shopping practices, and emotional 
eating.  The items on the questionnaire were rated on a 5-point scale ranging from “Never or 
Hardly Ever” to “Always or Almost Always.” The EBI has been established as a valid tool for 
measuring changes in body weight related food behaviors109. 
3.6 DEFINING SELF-MONITORING DATA FOR STATISTICAL ANALYSIS 
As defined in the specific aims, self-monitoring was compared in the 3 intervention groups 
(SBWL, TECH, and TECH-BT). Below, defined a priori criteria for self-monitoring of dietary 
intake, physical activity, and body weight was provided for data analysis. 
3.6.1 SBWL 
1. Dietary Intake: Dietary intake was self-monitored in a paper diary. Total frequency of self-
monitoring days, average days per week, and self-reported caloric intake across the 12-week 
intervention was measured.  
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2. Physical Activity: Physical activity will be self-monitored in a paper diary. Included in these 
measures were the total days, days per week, and minutes per week when physical activity 
behaviors were recorded.  
3. Body Weight: Body weight was self-monitored in a paper diary. Total frequency of self-
weighing days and the average number of days per week that body weight is self-monitored 
across the 12-week intervention will be measured.  
3.6.2 TECH and TECH-BT 
1. Dietary Intake:  Dietary intake was self-monitored using the web-based software program. 
Total frequency of self-monitoring days, average days per week, and self-reported caloric 
intake across the 12-week intervention was measured.  
2. Physical Activity: Physical activity was self-monitored based on armband wear-time as 
measured by the number of total days, days per week, total hours, hours per day, and percent 
time on-body. 
3. Body Weight: Body weight was self-monitored using the web-based software program. Total 
frequency of self-weighing days and the average number of days per week that body weight 
is self-monitored was measured.  
3.7 STATISTICAL ANALYSES 
Statistical analyses were completed using the Statistical Package for the Social Sciences (IBM-
SPSS, version 20.0). Statistical significance was defined at p < 0.05. For missing data at the 3 
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month assessment, baseline data were carried forward to allow for intention-to-treat analyses.  
The following outlines the analyses conducted for each of the proposed outcome variables. 
3.7.1 Descriptive Analyses 
1. Descriptive analyses were conducted to examine mean baseline characteristics such as age, 
body weight, BMI and adiposity along with measures of physical activity, and dietary intake.  
2. Descriptive analyses were conducted to examine process measures such as:  intervention 
contact, dietary and physical activity self-monitoring, frequency of self-weighing, and 
armband time-on-body.  
3.7.2 Data Analyses 
1. A 3 x 2 repeated measures (group by time) analysis of variance (ANOVA) was performed on 
body weight. A significant interaction effect (group by time) was further examined with post-
hoc comparisons using Bonferroni adjustment to explore for the TECH-BT versus SBWL 
and TECH-BT versus TECH.  An exploratory comparison of SBWL vs. TECH was also 
performed if a significant interaction effect (group by time) was observed in the ANOVA.    
2. A 3 x 2 repeated measures (group by time) analysis of variance (ANOVA) was performed for 
body composition. A significant interaction effect (group by time) was further examined with 
post-hoc comparisons using Bonferroni adjustment to explore for the TECH-BT versus 
SBWL and TECH-BT versus TECH.  An exploratory comparison of SBWL vs. TECH was 
also performed if a significant interaction effect (group by time) was observed in the 
ANOVA.    
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3. A 3 x 2 repeated measures (group by time) analysis of variance (ANOVA) was performed for 
physical activity assessed by questionnaire. A significant interaction effect (group by time) 
was further examined with post-hoc comparisons using Bonferroni adjustment to explore for 
the TECH-BT versus SBWL and TECH-BT versus TECH.  An exploratory comparison of 
SBWL vs. TECH was also performed if a significant interaction effect (group by time) was 
observed in the ANOVA.    
4. A 3 x 2 repeated measures (group by time) analysis of variance (ANOVA) was performed for 
dietary intake. A significant interaction effect (group by time) was further examined with 
post-hoc comparisons using Bonferroni adjustment to explore for the TECH-BT versus 
SBWL and TECH-BT versus TECH.  An exploratory comparison of SBWL vs. TECH was 
also performed if a significant interaction effect (group by time) was observed in the 
ANOVA.    
5. Descriptive statistics were performed for self-monitoring data (dietary intake, physical 
activity, and body weight) in SBWL, and independent samples t-tests were performed on 
self-monitoring data (dietary intake, physical activity, and body weight) in TECH and 
TECH-BT. Separate one-way ANOVAs were performed for self-monitoring data (self-report 
dietary intake) between SBWL, TECH, and TECH-BT.  Post-hoc comparisons using 
Bonferroni adjustment was conducted to compare TECH-BT versus SBWL and TECH-BT 
versus TECH.  An exploratory comparison of SBWL vs. TECH was also performed for self-
reported dietary intake. 
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3.8 POWER ANALYSIS 
The primary aim of this study was to examine if TECH-BT had greater change in body weight 
compared to both SBWL and TECH.  Based on other studies that have been 12 weeks in duration 
conducted at the Physical Activity and Weight Management Research Center at the University of 
Pittsburgh, it was estimated that the standard deviation for weight loss in each of the intervention 
conditions was 3.0 kg.  It was proposed that a clinically meaningful difference in weight loss 
between TECH-BT and either SBWL or TECH would be 2.5 kg.  The type I error rate was 0.05; 
however this was adjusted to 0.025 to allow for the two primary comparisons (TECH-BT vs. 
SBWL) and (TECH-BT vs. TECH). Based on these assumptions, a sample size of 25 subjects 
per group would allow for 75% power to detect the proposed differences in weight loss between 
the intervention conditions.  To allow for the potential of 10% attrition, 84 subjects were 
suggested for recruitment.  However, as described in detail in Chapter 4, 54 individuals 
consented to participant in this study, with 39 completing baseline assessments and being eligible 
for randomization to one of the three treatment groups (SBWL, TECH, TECH-BT). 
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4.0  RESULTS 
The purpose of this study was to examine the effectiveness of a technology –based, enhanced 
technology-based and standard behavioral weight loss intervention in Class II and III obese 
adults. This was a pretest-posttest randomized controlled weight loss trial with assessments 
conducted at 0 and 3 months of participation. The results of this study are presented below. 
4.1 SUBJECT CHARACTERISTICS 
Thirty-nine subjects between the ages of 21 to 55 years with a body mass index (BMI) ranging 
from 35.3 to 44.6 kg/m2 participated in this investigation at the Physical Activity and Weight 
Management Research Center at the University of Pittsburgh. Subjects had a mean BMI of 39.5 
± 2.8 kg/m2 at baseline and were predominantly female (79.5%). One-way analysis of variance 
(ANOVA) determined no significant differences between treatment groups for baseline age, 
body weight, BMI, systolic blood pressure (SBP), diastolic blood pressure (DBP), waist 
circumferences at both the umbilicus and iliac crest sites, hip circumference, percent body fat, 
self-reported moderate-to-vigorous physical activity (MVPA), and sedentary time. (Table 3) 
Significant differences were revealed for baseline resting heart rate (RHR) (p=.036) between 
treatment groups. Bonferroni post hoc analysis indicated a significantly higher baseline RHR in 
TECH compared to SBWL (p=.038).  
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Table 3. Differences in Baseline Characteristics by Treatment Group 
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Figure 5. Study recruitment, randomization and retention 
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Figure 6. Reasons for ineligibility based on telephone screening 
 
 
Figure 7. Reasons consented participants were not randomized 
Figure 5 illustrates subject recruitment, randomization and retention. Six-hundred sixty-
seven participants were initially called for a telephone screening and 464 (69.6%) participants 
consented to be screened after receiving information about the study. Of those screened, 105 
(22.6%) were eligible to participate and 359 (77.4%) were not. Fifty-nine participants attended 
Age, BMI24%
Medical Conditions45%
Technology22%
Exercise, Weight Loss or Treatment, Pregnancy7%
Other2%
No medical cosent20% No technology7%
High blood pressure7%Exclusionary medication13%
Time commitment issue13%
No show assessment40%
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an orientation and 54 consented to be a part of the study.  Following completion of baseline 
assessments, 39 subjects were randomized to one of the three treatment groups (SBWL, TECH, 
TECH-BT). Reasons for ineligibility are shown in Figures 5 and 6, and reasons for not being 
randomized after providing informed consent are shown in Figure 7. 
A total of 34 participants (87.2%) completed baseline and 3-month assessments and will 
be referred to as completers.  Participants who did not complete the 3-month assessment (N=5, 
12.8%) will be referred to as non-completers. Comparison of retention rates between groups 
using Pearson Chi-Square resulted in χ2 = 5.9 (p = 0.052).  Baseline characteristics between 
completers and non-completers are presented in Table 4. Independent samples t-tests showed no 
significant differences between completers and non-completers in any of the baseline 
characteristics.  
4.2 CHANGE IN BODY WEIGHT AND BMI 
A 3 x 2 repeated measures (group by time) ANOVA was performed to examine change in 
body weight and BMI from baseline to 3 months between the treatment groups. Results of the 
completers analysis indicated a significant weight loss from baseline to 3 months in SBWL (-3.4 
± 3.1 kg), TECH (-5.0 ± 3.7 kg), and TECH-BT (-4.8 ± 4.3 kg) (p<.001); however, there were no 
significant differences between the groups (p=.812) or group X time interaction (p=.499). (Table 
5). Percent weight loss was -4.3 ± 3.8% with no differences between treatment groups (SBWL: -
3.2 ± 2.8%; TECH: -4.9 ± 3.8%; TECH-BT: -5.0 ± 5.1%) (Figure 8). Body mass index also 
significantly decreased from baseline to 3 months (p<.001); however, there were also no 
significant differences between treatment groups (p=.963) or group X time interaction (p=.466). 
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Intent-to-treat analysis was conducted using all randomized participants with baseline 
data carried forward when 3-month data were missing. A 3 x 2 repeated measures (group by 
time) ANOVA was performed to examine body weight and BMI changes from baseline to 3 
months between the treatment groups. Results of the intent-to-treat analysis indicated a 
significant time effect for weight loss from baseline to 3 months in SBWL (-3.2 ± 3.1 kg) TECH 
(-5.0 ± 3.7 kg), and TECH-BT (-3.3 ± 4.2 kg) (p<.001); however, there were no significant 
differences between the groups (p=.990) or group X time interaction (p=.387) (Table 6). Percent 
weight loss was -3.7 ± 3.9% with no differences between treatment groups (SBWL: -2.9 ± 2.9%; 
TECH: -4.9 ± 3.8%; TECH-BT: -3.5 ± 4.8%) (Figure 8). Body mass index also significantly 
decreased from baseline to 3 months (p<.001); however, there were no significant differences 
between treatment groups (p=.981) or group X time interaction (p=.417).  
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Table 4. Differences in baseline characteristics by completers and non-completers 
 
 
 
 
  49 
Table 5. Completers analyses for change in outcomes between treatment groups at 3 
months (mean±SD) 
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Table 6. Intent-to-treat analyses for change in outcomes between treatment groups 
at 3 months (mean±SD) 
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Note: No statistical difference between groups in the completers and intent-to-treat analyses. 
Figure 8. Percent weight loss at 3 months among treatment groups: completers and 
intent-to-treat 
 
Chi-square analysis showed no differences between groups for those subjects achieving 
≥5% weight loss (χ2= 2.26, p=.323). The frequencies of those achieving ≥5% weight loss across 
3 months are shown in Table 7.  
 
Table 7. Frequencies by group for achieving ≥5% weight loss at 3 months 
 Total 
(N=39) 
SBWL 
(N=14) 
TECH 
(N=12) 
TECH-BT 
(N=13) 
Frequency 13 4 6 3 
Percent of Total 33.3% 28.5% 50.0% 23.1% 
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4.3 CHANGES IN SYSTOLIC AND DIASTOLIC BLOOD PRESSURE AND 
RESTING HEART RATE 
A 3 x 2 repeated measures (group by time) ANOVA was performed to examine changes from 
baseline to 3 months in systolic blood pressure (SBP), diastolic blood pressure (DBP) and RHR 
between the treatment groups. Completers analyses results are found in Table 5. Results 
indicated a significant time effect in SBP from baseline to 3 months in SBWL (-0.5 ± 5.3 
mmHg), TECH (-4.3 ± 9.0 mmHg), and TECH-BT (-4.6 ± 6.4 mmHg) (p=.016); however, there 
were no significant differences between the groups (p=.796) or group X time interaction 
(p=.305). Likewise, DBP significantly decreased from baseline to 3 months in SBWL (-5.5 ± 5.7 
mmHg), TECH (-3.0 ± 6.0 mmHg), and TECH-BT (-2.8 ± 4.6 mmHg) (p=.001); however, there 
were no significant differences between the groups (p=.609) or group X time interaction (.432). 
RHR significantly decreased from baseline to 3 months in SBWL (3.2 ± 8.0 beats/min), TECH 
(3.7 ± 11.1 beats/min), and TECH-BT (5.9 ± 6.0 beats/min) (p=.009). There was a significant 
group effect for RHR (p=.024) with Bonferroni post hoc analysis demonstrating a lower RHR in 
SBWL compared to TECH (p=.022).  
Intent-to-treat analysis indicated a significant time effect in SBP in SBWL (-.5 ± 5.1 
mmHg), TECH (-4.3 ± 9.0 mmHg), and TECH-BT (-3.2 ± 5.7 mmHg)(p=.019), with no 
differences between groups (p=.695) or group X time interaction (.326).  Likewise, there was a 
significant time effect for DBP in SBWL (-0.4 ± 1.0 mmHg), TECH (-0.8 ± 1.9 mmHg), and 
TECH-BT (-0.2 ± 0.6 mmHg) (p=.031), and no differences between groups (p=.670) or group X 
time interaction (.462).  RHR significantly decreased from baseline to 3 months in SBWL (3.0 ± 
7.7 beats/min), TECH (3.7 ± 11.1 beats/min), and TECH-BT (4.1 ± 5.7 beats/min) (p=.012). 
There was a significant group effect for RHR (p=.020) with Bonferroni post hoc analysis 
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demonstrating a lower RHR in SBWL compared to TECH (p=.022).   These results are shown in 
Table 6.  
4.4 CHANGES IN ANTHROPOMETRIC MEASURES AND BODY COMPOSITION 
A 3 x 2 repeated measures (group by time) ANOVA demonstrated significant reductions in waist 
circumferences at both the umbilicus (p<.001)  and iliac crest (p<.001) sites at 3 months for 
completers in SBWL (umbilicus: -4.3 ± 3.8 cm, iliac: -3.7 ± 5.6 cm), TECH (umbilicus: -6.8 ± 
4.7 cm, iliac: -6.4 ± 8.3 cm), and TECH-BT (umbilicus: -8.9 ± 5.9 cm, iliac: -5.4 ± 5.0 cm). No 
group differences were observed between groups for umbilicus (p=.692) and iliac (p=.875) sites 
or group X time interactions (umbilicus: p=.100, iliac: p=.594).  Similarly, a significant time 
effect was found for reduction in hip circumference in SBWL (-3.6 ± 3.6 cm), TECH (-5.3 ± 2.8 
cm) and TECH-BT (-5.3 ± 3.5 cm) (p<.001), with no group differences observed (p=.708) or 
group X time interaction (p=.366).  A significant time effect was found for reductions in percent 
body fat in SBWL (-1.1 ± 1.8%), TECH (-1.2 ± 2.0%), and TECH-BT (-1.7 ± 1.7%) (p<.001), with no 
group differences (p=.925) or group X time interaction (.690).  Results are shown in Table 5. 
Intent-to-treat analysis revealed significant reductions in waist circumferences at both the 
umbilicus (p<.001) and iliac crest (p<.001) sites at 3 months for completers in SBWL 
(umbilicus: -4.0 ± 3.9 cm,  iliac: -3.5 ± 5.5 cm), TECH (umbilicus: -6.8 ±  4.7 cm, iliac: -6.4 ± 
8.3 cm), and TECH-BT (umbilicus: -6.1 ±  6.4 cm, iliac: -3.8 ± 4.9 cm). No group differences 
were observed between groups for umbilicus (p=.895) and iliac (p=.663) sites, or group X time 
interactions (umbilicus: p=.362, iliac: p=.448).  A significant time effect was also found for 
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reduction in hip circumference in SBWL (-3.4 ± 3.6 cm), TECH (-5.3 ± 2.8 cm), and TECH-BT 
(-3.7 ± 3.8 cm) (p<.001), with no group differences observed (p=.773) or group X time 
interactions (p=.332). A significant time effect was found for reductions in percent body fat in 
SBWL (-1.0 ± 1.7%), TECH (-1.2 ± 2.0%), and TECH-BT (-1.2 ± 1.6%) (p<.001), with no group 
differences observed (p=.874) or group X time interaction (p=.958). Results are shown in Table 
6.  
4.5 CHANGES IN PHYSICAL ACTIVITY 
A 3 x 2 repeated measures (group by time) ANOVA was performed to examine changes from 
baseline to 3 months in MVPA (hours/wk) and sedentary time (hours/day) between the treatment 
groups. Completers analyses results are found in Table 5. Results indicated a significant time 
effect for both MVPA (p=.020) and sedentary time (p=.010), with MVPA increasing and 
sedentary time decreasing from baseline to 3 months.  However, there were no significant 
differences between the groups (p=.147 and .766) or group X time interactions (p=.533 and .683) 
for either MVPA or sedentary time respectively.   Intention-to-treat analyses showed similar 
patterns for both MVPA and sedentary time (Table 6). 
4.6 CHANGES IN DIETARY INTAKE AND EATING BEHAVIOR 
A 3 x 2 repeated measures (group by time) ANOVA was also performed to examine changes 
from baseline to 3 months in energy intake measured from a food frequency questionnaire 
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between the treatment groups. Results for the completers analysis are found in Table 5. Results 
indicated a significant time effect (p=.037) for reduction in energy intake with a mean of 
254.9±640.6 kcal/day.  However, there were no significant differences between the groups 
(p=.162) or group X time interactions (p=.963). A similar pattern of results were shown for the 
intent-to-treat analysis (Table 6). 
A 3 x 2 repeated measures (group by time) ANOVA was also performed to examine 
changes from baseline to 3 months in percent of calories consumed as dietary fat measured from 
a food frequency questionnaire between the treatment groups. Results for the completers analysis 
are found in Table 5. Results indicated a significant time effect (p=.223) for reduction in percent 
dietary fat intake with a mean of 2.4±5.5%.  However, there were no significant differences 
between the groups (p=.162) or group X time interactions (p=.806). A similar pattern of results 
were shown for the intent-to-treat analysis (Table 6). 
A 3 x 2 repeated measures (group by time) ANOVA was performed to examine changes 
from baseline to 3 months in Eating Behavior Index (EBI) scores between the treatment groups. 
Results for the completers analysis are found in Table 5. Results indicated a significant time 
effect (p<.001) for improvement in score.  However, there were no significant differences 
between the groups (p=.158) or group X time interactions (p=.985). Intent-to-treat analysis 
(Table 6) demonstrated a significant time effect (p<.001) for improvement in score as well. 
There was also a significant group effect (p=.034) with Bonferroni post hoc analysis 
demonstrating a difference between TECH-BT and SBWL (p=.032).  
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4.7 PROCESS MEASURES 
Descriptive analyses were used to examine process measures of attendance at weekly group 
meetings, monthly telephone call completion, and self-monitoring of dietary intake, physical 
activity, and weight. Due to differences in these measures across group interventions, 
independent samples t-test were used to examine differences in the process measures between 
the technology groups (TECH, TECH-BT), and descriptive statistics were used for SBWL.   
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Table 8. Completers Analyses: Differences in process measures between groups 
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Table 9. Intent-to-treat analyses: differences in process measures between groups 
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4.7.1 Attendance and Telephone Call Completion 
Attendance at weekly group meetings was 72.4 ± 19.9% among completers in SBWL. TECH 
and TECH-BT did not attend weekly meetings and instead received monthly telephone calls. 
Telephone call completion rates were 91.7 ± 15.1% and 74.1 ± 27.8% for TECH and TECH-BT 
respectively, with no differences between groups (p=.077) (Table 8). Intent-to-treat analysis 
revealed a weekly group attendance of 69.0 ± 23.0% for SBWL. Telephone call completion rates 
were 91.7 ± 15.1% and 64.1 ± 28.7% for TECH and TECH-BT respectively, with TECH 
completing significantly more telephone calls compared to TECH-BT (p=.007) (Table 9).   
4.7.2 Dietary Self-monitoring 
The total number of self-monitoring paper diaries completed for completers in SBWL was on 
average 7.9 ± 4.1 diaries (66%) across 12 weeks (Table 8). SBWL recorded dietary intake in a 
paper diary 53.3 ± 27.5 total days or 4.4 ± 2.3 days/week. TECH used the online website and 
TECH-BT used the online website or smartphone device to self-monitor dietary intake. Total 
days of dietary intake self-monitoring were 52.2 ± 23.0 (TECH) and 54.0 ± 29.4 (TECH-BT), 
and days per week of dietary intake self-monitoring were 4.3 ± 1.9 (TECH) and 4.5 ± 2.4 
(TECH-BT) with no differences between groups (p=.874). The mean self-reported caloric intake 
was 1112.9 ± 489.4 kcal/day, 969.6 ± 607.2 kcal/day, and 873.4 ± 521.0 kcal/day for SBWL, 
TECH and TECH-BT, respectively, with no differences between groups (p=.707).  One-way 
ANOVA was used to determine mean differences between SBWL, TECH, and TECH-BT. No 
significant differences were found between groups for total days self-monitored (p=.572), days 
per week self-monitored (p=.572), and mean self reported caloric intake (p=.173).  
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Intent-to-treat analysis revealed that the total number of self-monitoring paper diaries 
completed for SBWL was 7.6 ± 4.1 diaries (63%) across 12 weeks (Table 9). SBWL recorded 
dietary intake in a paper diary 51.5 ± 27.3 total days and 4.3 ± 2.3 days/week. Self-monitoring of 
dietary intake for the technology groups was 52.2 ± 23.0 and 41.9 ± 30.8 total days for TECH 
and TECH-BT respectively; and 4.3 ± 1.9 and 3.5 ± 2.6 days/week for TECH and TECH-BT 
respectively. No differences were reported between groups (p=.360). Average caloric intake for 
SBWL was 1112.9 ± 489.4 kcal/day, and caloric intake for the technology groups was 969.6 ± 
607.2 and 864.5 ± 535.4 kcals per day for TECH and TECH-BT respectively. No differences 
were reported between the technology groups (p=.209).  
4.7.3 Physical Activity Self-monitoring 
Using the paper diary, completers in SBWL self-monitored physical activity 30.7 ± 22.5 total 
days; 2.6 ± 1.8 days per week; and reported 104.6 ± 84.3 minutes per week (Table 8). Different 
from SBWL, the technology groups (TECH, TECH-BT) used the armband to self-monitor 
physical activity.  The armband was worn for 68.8 ± 18.7 and 69.0 ± 19.7 total days for TECH 
and TECH-BT respectively; and 5.7 ± 1.6 and 5.8 ± 1.6 days per week for TECH and TECH-BT 
respectively. No differences were observed between groups (p=.977). Total hours of armband 
wear-time were 1098.2 ± 393.6 (TECH) and 1058.3 ± 446.3 (TECH-BT), with no differences 
between groups (p=.431). The armband was worn on average 14.0 ± 5.4 and 13.3 ± 5.6 hours per 
day for TECH and TECH-BT respectively, with no difference between groups (p=.332). Percent 
time on-body for TECH was 58.4 ± 22.6% and 55.4 ± 23.3% for TECH-BT, with no differences 
between groups (p=.759).  
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Intent-to-treat analysis revealed that SBWL self-monitored physical activity in the paper 
diary 28.9 ± 22.6 total days; 2.4 ± 1.9 days per week; and 98.3 ± 84.3 minutes per week (Table 
9). The technology groups (TECH, TECH-BT) wore the armband for 68.8 ± 18.7 and 59.5 ± 26.5 
total days for TECH and TECH-BT respectively; and 5.7 ± 1.6 and 5.0 ± 2.2 days per week for 
TECH and TECH-BT respectively. No differences were observed between groups (p=.329). 
Total hours of armband wear-time were 1098.2 ± 393.6 (TECH) and 889.1 ± 513.4 (TECH-BT), 
with no differences between groups (p=.268). The armband was worn on average 14.0 ± 5.4 and 
11.2 ± 6.5 hours per day for TECH and TECH-BT respectively, with no difference between 
groups (p=.260). Percent time on-body for TECH was 58.4 ± 22.6% and 46.8 ± 27.2% for 
TECH-BT, with no differences between groups (p=.260).  
4.7.4 Energy Expenditure 
Total daily energy expenditure was obtained from armband data for TECH and TECH-BT. 
Among completers, energy expenditure was not different between TECH (2886.8 ± 881.7 
kcal/day) and TECH-BT (2807.0 ± 539.1 kcal/day) (p=.814) (Table 8). Intent-to-treat analysis 
also demonstrated no significant differences between TECH (2886.8 ± 881.7 kcal/day) and 
TECH-BT (2560.0 ± 969.3 kcal/day) (p=0.388) (Table 9).  
4.7.5 Self-weighing 
Completers analysis revealed that SBWL self-weighed 5.2 ± 9.2 total days across 12-weeks and 
an average of 0.4 ± 0.8 days per week (Table 8). There was no difference in total days self-
weighed in TECH (16.6 ± 14.6 days) and TECH-BT (13.3 ± 7.1 days) (p=.546), and no 
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difference in self-weighing days per week in TECH (1.4 ± 1.2 days/week) and TECH-BT (1.1 ± 
0.6) (p=.546).  
Intent-to-treat analysis revealed that SBWL self-weighed 5.5 ± 8.9 total days across 12-
weeks and an average of 0.5 ± 0.7 days per week (Table 9). There was no difference in total days 
self-weighed in TECH (16.6 ± 14.6 days) and TECH-BT (10.5 ± 7.3) (p=.197), and no difference 
in self-weighing days per week in TECH (1.4 ± 1.2 days/week) and TECH-BT (0.9 ± 0.6) 
(p=.197).  
4.8 CORRELATIONS BETWEEN PROCESS MEASURES AND WEIGHT CHANGE 
Correlations were performed for completers (Table 10) and intent-to-treat (Table 11) analyses for 
3-month change in body weight and all process measures.  
4.8.1 Attendance and Telephone Call Completion 
Percent group meeting attendance in SBWL was not significantly related to weight loss at 3 
months in completers (r=.311, p=.301) or intent-to-treat (r=.410, p=.145) analyses. The 
technology groups were significantly correlated to telephone call completion in completers 
(TECH: r=.646, p=.023; TECH-BT: r=.736, p=.024), and intent-to-treat (TECH: r=.646, p=.023; 
TECH-BT: r=.782, p=.002) analyses. Results are presented in Tables 10 and 11.  
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Table 10. Completers analyses: correlations between process measures and 3-month 
weight loss 
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Table 11. Intent-to-treat analyses: correlations between process measures and 3-
month weight loss 
 
  65 
4.8.2 Dietary Self-monitoring 
Completers analysis revealed significant correlations for SBWL between weight loss at 3 months 
and number of diaries completed (r=.905, p<.001), total days intake recorded (r=.893, p<.001), 
days per week intake recorded (r=.893, p<.001), and average caloric intake per day (r=.830, 
p=.001) (Table 10). Weight loss in the technology groups was not significantly correlated with 
total days intake recorded (TECH: r=.112, p=.728; TECH-BT: r=.218, p=.574), days per week 
intake recorded (TECH: r=.112, p=.728; TECH-BT: r=.218, p=.574), and average caloric intake 
per day (TECH: r=-.018, p=.955; TECH-BT: r=.229, p=.554).  
Intent-to-treat analysis demonstrated similar results (Table 11). SBWL significantly 
correlated 3-month change in body weight to number of diaries completed (r=.911, p>.001); total 
days intake recorded (r=.900, p<.001); days per week intake recorded (r=.990, p<.001); and 
average caloric intake per day (r=.848, p<.001). However, weight loss in the technology groups 
was not significantly correlated with total days intake recorded (TECH: r=.112, p=.728; TECH-
BT: r=.477, p=.099); days per week intake recorded (TECH: r=.112, p=.728; TECH-BT: r=.477, 
p=.099); and average caloric intake per day (TECH: r=-.018, p=.955; TECH-BT: r=.470, 
p=.105).  
4.8.3 Armband Usage 
Completers analysis did not reveal any significant correlations for TECH between weight loss 
and total days worn (r=.414, p=.180); days per week worn (r=.414, p=.180); total hours worn 
(r=-.033, p=.918); hours per day worn (r=-.122, p=.706); and percent time on-body (r=-.122, 
p=.706) (Table 10). TECH-BT had a significant correlation between weight loss and total days 
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the armband was worn (r=.723, p=.028) and days per week the armband was worn (r=.723, 
p=.028); however, there was no significant relationship with change in body weight and total 
hours worn (r=.457, p=.216); hours per day worn (r=.400, p=.286); and percent time on-body 
(r=.400, p=.286).  
Intent-to-treat analysis revealed the same pattern of results.  For TECH, the correlations 
were not statistically significant between weight loss and total days the armband was worn 
(r=.414, p=.180), days per week the armband was worn (r=.414, p=.180), total hours the 
armband was worn (r=-.033, p=.918), hours per day the armband was worn (r=-.122, p=706), and 
percent time on-body for the armband (r=-.122, p=.706) (Table 11). For TECH-BT, the 
correlations were significant between weight loss and total days armband the armband was worn 
(r=.674, p=.012), days per week the armband was worn (r=.674, p=.012), and total hours worn 
the armband was worn (r=.554, p=.050);  however, no significant relationship was observed 
between change in body weight and hours per day the armband was worn (r=.506, p=.077) or 
percent time on-body for the armband (r=.506, p=.077). 
4.8.4 Energy Expenditure 
Daily energy expenditure was not significantly related to weight loss at 3 months in completers 
(TECH: r=.402, p=.195; TECH-BT: r=.314 , p=.410) or intent-to-treat (TECH: r=.402, p=.195; 
TECH-BT: r=.338, p= .259) analyses (Tables 10 and 11). 
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4.8.5 Self-weighing 
Completers analysis did not reveal any significant correlations between weight loss and total 
days of self-weighing for SBWL (r=.224, p=.462) and TECH (r=.492, p=.104); however, the 
correlation was significant in TECH-BT (r=.723, p=.028) (Table 10). Likewise, weight loss for 
SBWL (r=.224, p=.462) and TECH (r=.492, p=.104) were not significantly correlated with days 
per week of self-weighing; however, these were significantly correlated for TECH-BT (r=.723, 
p=.028).  
Intent-to-treat analysis demonstrated similar results (Table 11). Weight loss in SBWL 
(r=.169, p=.563) and TECH (r=.492, p=.104) was not correlated with total days of self-weighing; 
however, these variables were significantly correlated in TECH-BT (r=.674, p=.012).  A similar 
pattern of results was observed for the correlation between weight loss and days per week of self-
weighing (SBWL: r=.169, p=.563; TECH: r=.492, p=.104; TECH-BT: r=.674, p=.012).  
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5.0  DISCUSSION 
The purpose of this study was to examine the effectiveness of a technology-based, enhanced 
technology-based and standard behavioral weight loss intervention across 3 months in Class II 
and Class III obese adults. The technology-based system used in the investigation is the 
BodyMedia FIT System (BodyMedia Inc., Pittsburgh, PA).  Previous research using this type of 
technology alone has shown promising results in creating significant weight losses across 4-
month75 and 6-month76 interventions. Pellegrini et al35 found significant magnitudes of weight 
loss using this type of technology combined with monthly telephone contact with outcomes 
comparable to standard in-person interventions.  The current investigation examined the efficacy 
of this type of technology-based system with minimal in-person contact within Class II and Class 
III obese adults. Technology enhancements allowing for improved temporal proximity of self-
monitoring of dietary intake and feedback on energy balance have recently been added to the 
BodyMedia FIT System, allowing this study to further investigate the effectiveness of these 
technology improvements on weight loss and behavior change. 
5.1 PARTICIPANT RETENTION 
A total of 34 out of 39 randomized subjects completed the baseline and 3 month assessments, 
reflecting retention of 87% of subjects at 12 weeks.  This level of retention is comparable to what 
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is reported for short-term face-to-face weight loss interventions80, and is also within the range 
observed in previous studies using armband technology (71.1-89.2%)35,74,75. Attrition rates were 
7% for SBWL, 0% for TECH, and 31% for TECH-BT. The higher observed attrition for TECH-
BT may present an interesting finding, further investigation is needed to determine if this is due 
the different technology available to subjects in TECH-BT compared to TECH. The technology 
groups (TECH, TECH-BT) had a combined retention rate of 84% compared to 93% in SBWL. 
These results differ from those published by Polzien et al.74 and Pellegrini et al.33 which found 
lower retention rates among the standard in-person groups (53% and 84%) compared to those 
groups given armband technology (88% and 89%).  Whether this is a result of the currently study 
examining only individuals with Class II or III obesity is unable to be determined and warrants 
further investigation. 
5.2 BODY WEIGHT AND BMI 
The current investigation was successful in producing weight loss across all treatment groups in 
completers (SBWL: -3.4 ± 3.1 kg; TECH: -5.0 ± 3.7 kg; TECH-BT:-4.8 ± 4.3 kg) (p<.001), and 
intent-to-treat (SBWL: -3.2 ± 3.1 kg; TECH: -5.0 ± 3.7 kg; TECH-BT: -3.3 ± 4.2 kg) (p<.001) 
analyses. Overall combine weight change was -4.3% (completers) and -3.7% (intent-to-treat). 
This is within the range of weight loss expected following 10-12 weeks of a behavioral weight 
loss intervention (-4-5%)34 for completers, and slightly lower than expected with intent-to-treat 
analysis. Based on the results of completers and intent-to-treat analyses, the primary hypothesis 
that TECH-BT will result in a significantly greater weight loss compared to SBWL and TECH 
was not supported. Similar to previous studies using armband technology35,74, there were no 
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differences between groups for changes in body weight when comparing technology to standard 
in-person interventions. Thus, the TECH and TECH-BT interventions show promise in their 
ability to produce changes in body weight that are similar to what is achieved in SBWL 
programs.  
The weight loss achieved in both the TECH and TECH-BT interventions exceeds the 
weight loss achieved with the BodyMedia FIT System reported by Shuger et al75.  This may be a 
result of the current study combining the technology in TECH and TECH-BT with a brief once 
per month telephone call delivered by the intervention staff, whereas this telephone contact was 
not included in the intervention implemented by Shuger et al75. Additionally, the importance of 
these telephone calls may be further reflected in the finding that showed that the number of 
completed telephone calls was associated with weight loss achieved at 3-months.  While not 
decided to disentangle the influence of the technology from the telephone calls, it is possible that 
the telephone calls may have increased accountability, engagement, and motivation44 of the 
participants resulting in improved weight loss compared to what would have been achieved with 
the technology when not coupled with the telephone calls.  Other studies have also reported that 
the addition of personalized intervention contact to a technology-based intervention improves 
weight loss when compared to a technology program alone.  For example, within the context of a 
web-based intervention, Tate et al.71 found greater weight loss after 6 months when personalized 
feedback was provided via email from a counselor compared to automated computer feedback 
delivery.  
The technology enhancements in TECH-BT, which allowed for real time feedback of 
weight loss behaviors using a smart phone, did not further enhance the effectiveness of the 
technology for producing greater magnitudes of weight loss compared to TECH and SBWL as 
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originally hypothesized. However, this does not suggest that this technology is not necessary or 
appealing to achieve weight loss. Rather, it is possible that some individuals would prefer the 
TECH-BT system over the TECH system.  Thus, the finding that the TECH and TECH-BT 
groups achieved comparable weight loss, and that weight loss was also similar to what was 
achieved in SBWL suggests that all of these interventions can be used effectively.   Moreover, 
recent estimates indicate that approximately 50% of adult consumers in the United States own a 
smart phone,110 which was a component of the TECH-BT intervention.  Thus, while not more 
effective than either SBWL or TECH, TECH-BT may appeal to a segment of the population who 
find this technology appealing to use within the context of a health behavior change intervention 
program. Therefore, there are options for delivery of effective weight loss interventions, and 
decisions on which intervention approach to use may need to be based on the intervention that is 
most appealing to the participant.  
Although significant weight loss was achieved in all intervention conditions, it is 
important to note that on average the subjects of this study still remain categorized with Class II 
obesity following the 3-month intervention. Thus, interventions of longer duration appear 
necessary to effectively reduce BMI in this population. Moreover, whether the TECH and 
TECH-BT can continue to effectively reduce weight beyond 12 weeks in adults with Class II or 
III obesity warrants additional investigation.   
5.3 PROCESS MEASURES 
There were no differences between groups for the amount of self-monitoring of dietary intake 
that was done across the 3-month intervention, which does not support the a-priori hypothesis 
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that TECH-BT would self-monitor dietary behaviors more frequently than TECH and SBWL.  
The finding that the technology used in this study did not improve self-monitoring of dietary 
intake is consistent with the findings of other investigators35. It is also important to note that the 
technology did not hamper the ability of participants to self-monitor their eating behaviors when 
compared to the use of more traditional self-monitoring diaries.  These findings are important 
because self-monitoring of dietary behaviors has frequently been highlighted as being a key 
component of weight loss interventions36,76-84.  Unfortunately, the data collection methodology 
does not allow for additional analyses related to the quality or accuracy of the self-monitoring 
that occurred in this study, and whether this may have differed by intervention condition. 
There were no also differences between groups for the number of total days and days per 
week that body weight was self-monitored for both completers and intent-to-treat analyses. 
These results do not support the original hypothesis that TECH-BT would self-monitor body 
weight more frequently than TECH and SBWL. These results differ from those of Pellegrini et 
al.35 in which the technology-alone groups had a significantly lower number of days per week of 
self-weighing compared to the in-person intervention for both completers and intent-to-treat 
analyses. The results of this particular study do not show the hypothesized increase in frequency 
of self-weighing in the TECH-BT group; however, it should be noted that self-monitoring of 
body weight was not possible through the smart phone technology; only through the website 
interface. Given this limitation, it is not surprising that the TECH and TECH-BT groups had 
similar frequency of self-weighing days. Of note compared to the Pellegrini study35, the 
frequency of self-weighing in all groups was lower. Further investigation may be necessary to 
understand the reason for the overall reduced frequency of self-weighing in the Class II and III 
obese subjects.  
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Direct comparisons cannot be made between SBWL and the technology groups (TECH, 
TECH-BT) for process measures related to physical activity self-monitoring due to major 
differences in techniques used between the intervention conditions. However, armband wear-
time was able compared between TECH and TECH-BT. In this study, there were no differences 
between groups for armband wear-time for total days worn, days per week worn, total hours 
worn, hours per day worn, and percent time on-body for completers and intent-to-treat analyses. 
Completers analysis indicated that the technology subjects in this study worn the armband 5.7 
days per week (TECH) and 5.6 days per week (TECH-BT), for 14.0 hours per day (TECH) and 
13.3 hours per day (TECH-BT), which equates to a time on-body percent of 58.4% (TECH) and 
55.4% (TECH-BT). Similar results were seen with intent-to-treat analysis. Results from both 
analyses are similar to those reported by others for armband wear-time35. These results also 
reflect that adults with Class II or III obesity will use the armband technology to monitor 
physical activity and energy expenditure within the context of a weight loss intervention. 
5.4 EATING BEHAVIORS AND PHYSICAL ACTIVITY 
A key focus of the interventions implemented in this study was to improve the engagement in 
eating behaviors that have been shown to be important for weight loss.  In fact, all of the 
interventions (SBWL, TECH, TECH-BT) resulted in similar improvements in eating behavior 
(Table 5 and 6).  The mean improvement on the Eating Behavior Inventory (EBI) scale over this 
3 month intervention is slightly less than the improvement reported for studies that were 6 
months in duration35, 109.  An important finding in this study is that eating behavior improved in 
both TECH and TECH-BT, with this improvement being similar to the change that occurred in 
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SBWL.  Moreover, there were comparable reductions in energy intake and dietary fat intake as 
measured by a food frequency questionnaire.  Thus, these results suggest that a technology-based 
intervention combined with a once per month brief telephone contact with an interventionist can 
be effective in improving eating behaviors, reducing energy intake, and reducing fat intake in 
severely obese adults. 
Hours of self-reported moderate-to-vigorous physical activity (MVPA) significantly 
increased across all groups. However, the lack of a difference between the treatment groups 
rejects the original hypothesis suggesting that TECH-BT would have greater improvements in 
physical activity compared to TECH or SBWL. These results do demonstrate however that the 
technology is able to elicit similar improvements in physical activity as in-person interventions 
within Class II and III obese adults. Others have also reported on the ability for a SBWL 
program to increase physical activity in severely obese adults61, yet data are lacking on the 
effectiveness of non-in-person and technology-based intervention to improve physical activity in 
this population group.  It should also be noted that there were no serious adverse events in the 
current study resulting from engaging in physical activity.  This may suggest that when 
appropriately screen for contraindications for moderate-to-vigorous physical activity it is 
relatively safe to engage severely obese adults in interventions that promote engagement in this 
important weight loss behavior.  It is also important to highlight that all of the interventions were 
equally effective at reducing sedentary behavior in these severely obese adults.  This is an 
important finding as sedentary behavior has been implicated to increase health risk111.  
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5.5 CLINICAL IMPLICATIONS 
Obesity is a major health issue in the United States with approximately 33% of the population 
classified as obese1. It has also been shown that the treatment of obesity-related co-morbidities 
escalates health care costs22-24. However, even modest reductions in body weight have 
demonstrated improvements in health consequences related to obesity23-24. Thus, it is important 
to focus on intervention techniques for not only reducing body weight, but increasing the appeal 
of overweight and obese patients to participate in a weight loss interventions, which may require 
effective non-in-person interventions.  
The results of this study have demonstrated that short-term technology-based 
interventions combined with brief monthly telephone calls are as effective for weight loss as an 
in-person group based intervention. In addition, the reductions in body weight were accompanied 
by reductions in BMI, blood pressure, heart rate, anthropometric measures and sedentary time, 
and increases in physical activity and improved eating behaviors when compared to the in-person 
intervention. While it is recognized that this study was relatively short in duration (3 months), 
these findings provide optimism that may expand the portfolio of lifestyle intervention options 
available to effectively treat obesity. 
While this study does not allow for the intervention to be dismantled to determine the 
components of TECH or TECH-BT that were most important for weight loss success, one could 
speculate on how various components of the intervention may have contributed to weight loss 
success.  For example, using the technology to set intervention goals (physical activity, energy 
intake, weight loss) that can be viewed by the participant, using the technology to provide 
feedback on goal achievement, and having the interventionist use this information during the 
brief telephone contact each month to personalize this interaction may have collectively 
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contributed to the success of the TECH and TECH-BT to achieve weight loss in this study.  
Unfortunately, resources were not available to conduct a cost-effective analysis for this study to 
compare SBWL, TECH, and TECH-BT.  However, if shown to be more cost-effective, either the 
TECH or TECH-BT may provide a cost-effective weight loss option that may be appealing to a 
segment of overweight and obese adults seeking treatment.  A cost-effective option for weight 
loss in severely obese adults may also have appeal to clinical programs implemented in hospitals, 
through health insurance companies, or through community-based interventions, which may 
allow for broader dissemination of effective weight loss interventions.  
5.6 LIMITATIONS AND FUTURE DIRECTIONS 
This was the first study to specifically examine the effectiveness of TECH and TECH-BT 
compared to SBWL in severely obese adults.  Thus, this study was intended as a pilot study to 
inform a larger intervention trial to examine these interventions further.  However, it is 
recognized that there are limitations to this study as outlined below that may limit the 
interpretation of the findings reported, and these limitations should be considered in future 
research undertaken on this topic.  
1. This study randomized 39 subjects to start the interventions implemented in this study.  
However, the differences in weight loss between the groups were approximately 1-1.5 kg.  
While this information is valuable for adequately powering a larger clinical trial, this 
sample size was not sufficient to detect differences between groups for weight loss of this 
magnitude.  Thus, it cannot be determined definitively if these interventions result in 
similar magnitudes of weight loss or if differences between groups is not able to be 
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detected based on the sample size included in this study. With the sample size presented 
in this study, there was power to detect a 3.7 kg difference between groups. 
2. This study included 31 women and 8 men spread across the 3 intervention conditions.  
This is not sufficient to test for gender differences either within or between the 
intervention conditions, and therefore conclusions based on gender would be purely 
speculative. Thus, future studies should consider samples sizes that would allow for 
gender comparisons. 
3. This study included 28 Caucasians and 11 non-Caucasians spread across the 3 
intervention conditions.  This is not sufficient to test for racial/ethnic differences either 
within or between the intervention conditions, and therefore conclusions based on 
race/ethnicity would be purely speculative. Thus, future studies should consider samples 
sizes that would allow for racial/ethnic group comparisons. 
4. The current study was 3 months in duration.  This is similar in duration to the study 
conducted by Polzien et al.74 yet somewhat less that the 6 month duration of the study 
conducted by Pellegrini et al35. Unique to the current study is the focus specifically on the 
effectiveness of these interventions in adults with severe obesity (Class II and III 
obesity).  Thus, conclusion regarding the effectiveness of these interventions, specifically 
TECH and TECH-BT for weight loss in severely obese adults cannot be determined 
beyond the 3 months examined in this study.  Future studies should be conducted that are 
longer in duration to allow for the long-term effectiveness of these interventions to be 
examined.  
5. The current study examined the effectiveness of technology when combined with a brief 
monthly intervention telephone contact.  Thus, the current study is not able to determine 
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the extent that combination of the technology and telephone calls had on weight loss 
compared to either of these intervention strategies if implemented alone in a group of 
severely obese adults.  Future studies should be conducted to determine the contribution 
of each of these intervention strategies when used alone on weight loss in severely obese 
adults, as this may inform dissemination of these findings within clinical intervention 
programs.  
6. While this study examined severely obese adults, these individuals did not necessarily 
present with significant risk factors (e.g., hypertension, hyperlipidemia, hyperglycemia, 
hyperinsulinemia) for other chronic diseases, which limits the ability of this study to 
determine if the interventions would have resulted in differential effects on these 
outcomes. Future studies should consider recruiting severely obese adults who also 
present with additional risk factors or metabolic conditions (e.g., diabetes mellitus, etc.) 
to determine if the interventions can influence these outcomes. 
5.7 SUMMARY 
In summary, this study demonstrated that short-term technology-based interventions combined 
with brief monthly telephone calls are as effective for weight loss as an in-person group based 
intervention in adults with severe obesity (BMI: 35 to 45 kg/m2). The observed weight loss was 
also accompanied by reductions in BMI, blood pressure, heart rate, anthropometric measures and 
sedentary time, and increases in physical activity and improved eating behaviors.  These findings 
were observed regardless of the intervention condition (SBWL, TECH, TECH-BT).  Thus, these 
findings provide initial evidence that short-term weight loss interventions can be successfully 
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implemented in a variety of ways with similar effectiveness in adults with severe obesity, which 
suggests that there are options for how to deliver weight loss interventions in this population 
group.  Whether these interventions can be equally effective across a longer intervention period 
or within subgroups (men vs. women, different race/ethnic groups, etc.), or if there are 
differences in cost-effectiveness of these interventions, warrants further investigation.  However, 
these results provide promise for implementing non-surgical or non-pharmacological 
interventions that focus solely on lifestyle modification for weight loss in adults with severe 
obesity. 
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APPENDIX A 
RECRUITMENT FORM 
Thank you for your interest in our program.  My name is __________ and I would briefly like to 
tell you about this research program. 
 
Procedure for Describing the Study and Obtaining Verbal Consent to Conduct the Phone 
Screen:  A description of the study will be read to participants, and this description includes 
important components of the informed consent process (see attached script).  Individuals who 
express an interest in participating in this study will be told the following to obtain verbal 
consent:   
• Investigators Component of Informed Consent:  This study is being 
conducted by Renee J. Rogers and Dr. John M. Jakicic at the University of 
Pittsburgh. 
 
• Description Component of Informed Consent: We are interested in 
recruiting 84 men and women to participate in this study.  This study will 
examine the influence of a technology-based system during a behavioral 
weight loss intervention on weight loss and exercise participation.  To do this, 
eligible individuals will participate in a 6-month program that will assist you 
with changing your dietary habits and increasing your exercise.  You will be 
randomly assigned to receive one of three weight loss interventions, which 
means that you cannot select the intervention that you receive, but it will be 
determined by a method similar to flipping a coin.  All groups will receive a 
weight loss program that includes changes in your diet and exercise. The first 
group will attend group and individual meetings regularly across the 6 
months.  The other two groups will be given a technology-based system to 
use over the 6 months that includes wearing an activity monitor that is worn 
on the upper arm which assesses the amount of energy you burn and logging 
into the Internet each day, and these groups will also receive periodic phone 
calls from the staff.  The weight loss intervention will be held at a University of 
Pittsburgh facility located on the South Side of Pittsburgh, and meetings will 
start between 5:30 and 6:00 in the evening, and these will be held on (Day of 
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Week to be determined).   Individuals who are eligible to participate in this 
study will undergo assessments of body weight, body composition which 
assesses the amount of fat and lean weight on their body, and fitness.  These 
assessments will be completed before you start the study and at 3 and 6 
months. If you complete this study you can earn up to $50.00.  
 
• If you are interested in participating in this study, I will need to ask you a few 
questions about your demographic background, physical health, and medical 
history to determine if you appear to be eligible to participate in this study.  It 
will take approximately 5 minutes to ask you all of the questions.  If we 
complete the interview, I will ask you for some specific information (your 
complete name, date of birth, and mailing address) so that we can contact 
you regarding your participation in this study.  I will then schedule you to 
attend an orientation session that will explain all of the procedures of this 
study in greater detail.  
 
• Confidentiality Component of Informed Consent: If your answer to a 
particular question tells me clearly that you will not be eligible for this study, I 
will stop the interview, and not ask you any more personal questions. 
 
 
• Right to Participate or Withdraw from Participation Component of 
Informed Consent: Your responses to these questions are confidential, and 
the information related to your health history or current behaviors that you are 
about to give me will be destroyed after this interview even if you are found to 
be eligible.  
 
• Do you have any questions related to any of the information that I have 
provided to you?  Staff member will answer any questions or will defer these 
questions to the Principal Investigator or Co-Investigator when appropriate 
prior to proceeding.  If the individual would like to think about their 
participation prior to proceeding with the Phone Screen, they will be provided 
with the telephone number that they can call if they decide to participate in the 
future. 
 
Voluntary Consent Component of Informed Consent:   
 
• Do you agree that the procedures that will be used to conduct this Phone 
Screen have been described to you, all of your questions have been answered, 
and you give me permission to ask you questions now as part of the initial 
Phone Screen?  If “YES” indicate the participant’s agreement with this statement on 
the top of the next page, and sign your name and date the form, and then complete 
the Phone Screen.  If “NO”, thank the individual for calling and do not complete the 
Phone Screen.  
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Phone Screen Interview 
The caller gives verbal permission to conduct the Phone Screen: _____  YES______  NO 
Verbal Assent was given to: ___________________________________________ 
Staff Member Signature: ___________________________________ 
Date Verbal Assent was given: ______________________________ 
Eligible based on telephone screening:   Yes  No  
If “No”, list reason for ineligibility: _____________________________________ 
1. Gender:  Male  Female 
2.a. Age:  (21-55)   
2.b.Date of Birth: //  
 
3.  Which of the following best describes your racial heritage? (you may choose more than one 
category): 
 American Indian or Alaska Native 
 Asian 
 Black or African-American 
 Hispanic, Latino, or Cape Verdean 
 Native Hawaiian or Other Pacific Islander 
 White 
 Other (Specify:__________________) 
 
4.  Current Weight:  pounds Office Use: BMI = _______(25-40 kg/m2) 
5.  Current Height: feet  inches 
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6.  Are you able to walk for exercise?         YES  No 
If “no”, specify reason: __________________________________________ 
 
7.   Do you currently exercise regularly at least once per week at a moderate intensity for at least 
20 minutes?         Yes  NO 
If “yes”, How many days per week? ________ 
 If “yes”, How long have you been exercising this way?____________ 
 
8. Have you ever been told by a doctor or other medical person that you have any of the 
following conditions? If “yes”, Specify: 
 a. Heart Disease   Yes  NO  ________________________ 
 b. Angina    Yes  NO  ________________________ 
 c. Hypertension   Yes  NO  ________________________ 
 d. Heart Attack   Yes  NO  ________________________ 
 e. Stroke    Yes  NO  ________________________ 
 f. Diabetes (sugar)   Yes  NO  ________________________ 
 g. Cancer   Yes  NO  ________________________ 
 
9.  Are you presently being treated by a doctor or other medical person for any other 
physical or  psychological problems?       Yes  NO 
  
If “yes”, specify: _________________________________________ 
 
10.  Do you take any prescription medications (includes psychotropics)?   Yes NO 
 If “yes”, specify the following: 
Medication Name Used to Treat: 
  
  
 
11.  Are you taking any medications for the purpose of weight loss?  Yes NO 
 If “yes”, specify: _________________________________________ 
 
12.  Are you currently a member of another organized exercise or are you participating in an   
               organized weight reduction program?      Yes  NO 
 
If “yes”, specify: _________________________________________ 
 
13.  Have you lost >5% or more pounds within the past 3 months?   Yes  NO 
 
If “yes”, specify number of pounds: ____Method used:_____________________ 
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14.  Are you currently participating in other research studies?    Yes  NO 
   
If “yes”, specify: _________________________________________ 
 
15. Have you been a participant in a previous exercise or weight control study? 
           Yes NO 
  
If “yes”, specify:__________________________________________ 
 
15.   Do you have daily access to a computer?     YES  No 
  
If “yes”, do you know how to use this computer?   YES  No 
 
If “yes”, where is this computer located?_________________________________ 
 
16.   Do you have daily access to the Internet?     YES  No 
  
If “yes”, do you know how to access the Internet?   YES  No 
 
If “yes”, what service do you use to access the Internet? ____________________ 
 
17.   Do you a smartphone that is an iphone or a phone that is powered with the Android 
Operating System?        YES  No 
 
If “yes”, provide the type of smartphone?    ______________________________ 
 
18. Do you plan to spend any time out of town on vacation or business in the next 6 months 
that may affect your ability to attend weekly group meetings?   Yes  NO 
  
If “yes”, specify: _________________________________________ 
 
19. Do you plan on relocating outside of the Greater Pittsburgh Area within the next 6 
months?          Yes  NO 
 If “yes”, specify: _________________________________________ 
 
 
WOMEN ONLY COMPLETE THE FOLLOWING QUESTIONS 
20. a.    Are you currently pregnant?       Yes  NO 
b.  Have you been pregnant in the last 6 months?      Yes  NO 
c.  Breast feeding in the last 3 months       Yes  NO 
d.  Do you plan on becoming pregnant in the next 3 months?   Yes  NO 
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Contact Tracking Form 
 
** THIS PAGE IS COMPLETED ONLY IF THE RESPONDANT APPEARS TO QUALIFY 
FOR PARTICIPATION IN THIS STUDY AND IS SCHEDULE FOR THE ORIENTATION 
VISIT. ** 
 
Date: ____/____/____ Staff Member Completing Form: ___________________ 
 
Name: _______________________________________________________ 
Street Address: ________________________________________________ 
City: _____________________________   State: ___  Zip Code:________ 
Home Phone: ___________________ Work Phone: ___________________ 
 
OFFICE USE ONLY:  
Eligible:     Yes   No  
Invited to Orientation:  Yes   No  
Date of Orientation:____/____/____ 
 
If eligible schedule the participant for their group orientation session based on the 
schedule of available dates.  A follow-up reminder will be send via the mail. 
 
PAGE 1 WILL BE RETAINED FOR DEMOGRAPHIC STATISTICS 
PAGES 2-3 MUST BE SHREDDED AT THE CONCLUSION OF THIS INTERVIEW 
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APPENDIX B 
TELEPHONE CONTACT FORM 
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APPENDIX C 
INTERVENTION SCHEDULE – COHORT 1 
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APPENDIX D 
INTERVENTION SCHEDULE – COHORT 2 
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